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ABSTRACT 
 
Seven Newcastle disease virus (NDV) strains and isolates were propagated in 
chicken embryonated eggs and identified by hemagglutination test (HI). Genomic 
RNA was extracted from allantoic fluid harvests of the studied viruses. Two 
reverse transcription-polymerase chain reactions (RT-PCR) were developed, which 
amplified 984 and 1412 bp of the fusion protein gene (F gene) of NDV strains TY-
1/90, DIK-90, DONGOLA, GD.S.1,  I 2, LASOTA, CLONE 30 using two sets of 
gene specific primers. Following sequencing, nucleotide sequences were annotated 
and 894 bp were compared phylogenetically with those from strains previously 
reported in the Sudan and reference strains from the Genbank®. 
It could be shown that TY-1/90 and DIK-90 strains isolated from Tyba and 
Dikhainat towns in Sudan in 1990, respectively, belong to the genotype VI subtype 
(VIb) of NDV genotypes and were in close genetic relationship to earlier Sudanese 
isolates of the mid-1970s, suggesting that Sudanese genotype VI subtype VIb was 
genetically stable and circulating over at least 15 years. Earlier Sudanese isolates 
were in turn genetically related to the European pigeons paramyxovirus type 1 
(PPMV-1) responsible for panzootic outbreaks of PPMV-1 in pigeon in the 1980s. 
It could thus be postulated, based on our findings, that this Sudanese strain of NDV 
might be the origin of, or share a common ancestor with, the European pigeon’s 
paramyxovirus type 1 (PPMV-1) in the 1980s. 
Dongola, GD.S.1 strains and the vaccinal strains (I 2, LASOTA, and CLONE 30) 
were classified into genotype II that comprises non-pathogenic lentogenic NDV 
strains. 
The present genetic classification of NDV isolates of the Sudan provides valuable 
information, which is fundamental for improving the efficiency of controlling 
strategies and vaccine development. 
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  ﺺﻠﺨﺴﺘﻤاﻟ
ﺧﺘﺒﺎر ﺗﺜﺒﻴﻂ ﺈهﺎ ﻓﻲ ﺟﻨﻴﻦ اﻟﺒﻴﺾ اﻟﻨﺎﻣﻲ واﻟﺘﻌﺮف ﻋﻠﻴﻬﺎ ﺑرآﺜﺎإ ﺳﻞ ﺗﻢﺎﺳﺒﻌﺔ ﺳﻼﻻت ﻣﻦ ﻓﻴﺮوس ﻣﺮض اﻟﻨﻴﻮآ
ﻃﻮرت  ﻃﺮﻳﻘﺘﻴﻦ ﻣﻦ  .ﻟﻠﺒﻴﺾ ﺳﺘﺨﻠﺺ ﺟﻴﻨﻮم اﻟﻔﻴﺮوﺳﺎت اﻟﻤﺪروﺳﺔ ﻣﻦ ﺳﺎﺋﻞ اﻟﺘﺠﻮﻳﻒ اﻟﺴﻘﺎﺋﻲأﺛﻢ  اﻟﺘﻼزن
و  489ﺿﺨﻤﺖ اﻟﻤﻨﻄﻘﺔ اﻟﻤﺤﺘﻮﻳﺔ ﻋﻠﻲ  و( RCP‐TR)ﻃﺮق إﺧﺘﺒﺎرﻋﻜﺲ ﻧﺴﺦ ﺗﻔﺎﻋﻼت اﻟﺒﻮﻟﻴﻤﺮﻳﺰ 
 ,09/1‐YT ﻟﻠﺴﻼﻻت( eneg nietorp noisuF) ﻣﻦ ﺟﻴﻦ اﻻﻧﺪﻣﺎج (sriap esab) اﻟﻘﺎﻋﺪة ﺛﻨﺎﺋﻴﺔ2141
ﺳﺘﺨﺪام ﺈﻣﻦ ﻓﻴﺮوس ﻣﺮض اﻟﻨﻴﻮآﺎﺳﻞ ﺑ 03 ENOLC ATOSAL  ,2I  ,1.S.DG ,ALOGNOD ,09‐KID
ﻗﻮرﻧﺖ ﺳﻠﺴﻠﺔ اﻟﻨﻴﻮآﻠﻮﺗﻴﺪات  (.sremirp  cificeps  eneG) اديء اﻟﻤﺘﺨﺼﺼﻪ ﻟﻠﺠﻴﻦﻮﻧﻮﻋﻴﻦ ﻣﻦ اﻟﺒ
ﻦ ﺑﻨﻚ ﺛﻨﺎﺋﻴﺔ اﻟﻘﺎﻋﺪﻩ ﻋﺮﻗﻴﺎ ﻣﻊ اﻟﺴﻼﻻت اﻟﻤﺴﺠﻠﻪ ﺳﺎﺑﻘﺎ ﻓﻲ اﻟﺴﻮدان وﻣﺮاﺟﻊ اﻟﺴﻼﻻت ﻣ 498اﻟﻤﺤﺘﻮﻳﻪ ﻋﻠﻲ 
  .اﻟﺠﻴﻨﺎت
ﻓﻲ اﻟﺴﻮدان ﻋﺎم  ﻨﺎت و ﻃﻴﺒﺔﻴاﻟﺘﻲ ﻋﺰﻟﺖ ﻣﻦ ﻣﺪﻳﻨﺔ اﻟﺪﻳﺨ (09‐KID ,09/1‐YT) ﺗﻢ ﺗﻮﺿﻴﺢ ان اﻟﺴﻼﻻت
ﺟﻴﻨﻴﻪ وﺛﻴﻘﺔ ﻣﻊ اﻟﺴﻼﻻت  وذات ﻋﻼﻗﺔ (b)ﺗﺤﺖ اﻟﻨﻮع  6رﻗﻢﻋﻠﻲ اﻟﺘﻮاﻟﻲ ﺗﻨﺘﻤﻲ اﻟﻲ اﻟﻨﻮع اﻟﺠﻴﻨﻲ  0991
 واﻧﺘﺸﺮﺛﺎﺑﺖ ﺟﻴﻨﻴًﺎ  (b)وﺗﺤﺖ اﻟﻨﻮع  6 ﻣﻤﺎ ﻳﺮﺟﺢ ان اﻟﻨﻮع اﻟﺴﻮداﻧﻴﺔ اﻟﻤﻌﺰوﻟﺔ ﻓﻲ ﻣﻨﺘﺼﻒ اﻟﺴﺒﻌﻴﻨﺎت
ﺤﻮاﻟﻲ ﺧﻤﺴﺔ ﻋﺸﺮ ﻋﺎم ﻓﻲ اﻟﺴﻮدان واﻟﺘﻲ ﺗﺮﺗﺒﻂ ﺟﻴﻨﻴًﺎ ﻣﻊ اﻟﻮﺑﺎء اﻟﻨﺎﺗﺞ ﻋﻦ ﻓﻴﺮوس اﻟﻨﻴﻮآﺎﺳﻞ ﻓﻲ اﻟﺤﻤﺎم ﻓﻲ ﻟ
  .وروﺑﺎ ﻓﻲ اﻟﺜﻤﺎﻧﻴﻨﺎتأ
ﻧﻬﺎ ﺗﻤﺘﻠﻚ ﺳﻠﻒ أو أﺻﻞ ﻷهﻲ ا ﺔاﻟﺴﻮداﻧﻴ ﺔن اﻟﺴﻼﻟأﺳﺘﻨﺎدا ﻋﻠﻲ اﻟﻨﺘﺎﺋﺞ اﻟﺘﻲ ﺗﻮﺻﻠﻨﺎ اﻟﻴﻬﺎ ﻳﻤﻜﻦ اﻓﺘﺮاض إ
  .ﺘﺮك ﻣﻊ اﻟﻔﻴﺮوس اﻻوروﺑﻲ ﻓﻲ اﻟﺤﻤﺎم ﻓﻲ اﻟﺜﻤﺎﻧﻴﻨﺎتﻣﺸ
 ﺗﺒﻌﺎ ﻟﻠﻨﻮع (2I  ,03 ENOLC ,ATOSAL) ﻘﺎﺣﻴﻪاﻟﻠواﻟﺴﻼﻻت  (1.S.DG ،ALOGNOD ) ﺘﻰﺻﻨﻔﺖ ﺳﻼﻟ
  .اﻟﺬي ﻳﻀﻢ  ﺳﻼﻻت ﻏﻴﺮ ﻣﻤﺮﺿﻪ ﻣﻦ اﻟﻔﻴﺮوس  و  2رﻗﻢ اﻟﺠﻴﻨﻲ 
ﺳﺎﺳﻲ أﻣﺮ أوهﻮ ، ﻣﺎت ﻗﻴﻤﻪﻮﻓﺮ ﻣﻌﻠﻮاﻟﺘﺼﻨﻴﻒ اﻟﺠﻴﻨﻲ اﻟﺤﺎﻟﻲ ﻟﻔﻴﺮوس اﻟﻨﻴﻮآﺎﺳﻞ اﻟﻤﻌﺰول ﻓﻲ اﻟﺴﻮدان ﻳ
 .ﺳﺘﺮاﺗﻴﺠﻴﺎت اﻟﺴﻴﻄﺮﻩ وﺗﻄﻮﻳﺮ اﻟﻠﻘﺎحإﻟﺘﺤﺴﻴﻦ آﻔﺎءة 
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INTRODUCTION 
 
Newcastle disease (ND) or avian paramyxovirus 1 infection (Alexander, 1997) is a 
viral disease of domestic poultry and wild birds. Gastrointestinal, respiratory and 
neurological signs of NDV infections of poultry range from inapparent to rapidly 
fatal depending upon the pathotype of virus involved (Alexander, 2003). The 
disease is highly contagious and affects over 250 species of birds of all age groups 
(Alexander et al., 1997).  
In the current virus taxonomy, Newcastle disease virus (NDV), or avian 
paramyxovirus type 1 (APMV-l), is classified with the other avian 
paramyxoviruses in the genus Avulavirus, sub-family Paramyxovirinae, family 
Paramyxoviridae, order Mononegavirales (Lamb et al., 2000; Mayo, 2002). 
Chickens infected with NDV may show clinical signs varying from extremely mild 
respiratory or enteric disease (avirulent viruses) to severe systemic infection, 
resulting in high mortality (virulent viruses) and characterized by very rapid 
spread. Newcastle disease is considered such a threat to poultry that it is included 
in the Office International des Epizooties (OIE) List A and its control is the subject 
of legislation in many parts of the world (Commission of the European 
Communities, 1992). Rapid detection and assessment of the virulence of NDV is 
essential to ensure that outbreaks are contained and their impact is minimized. 
Detection and characterization of NDV can be carried out by many different 
methods (Aldous and Alexander, 2001). Analysis of the binding patterns of a panel 
of monoclonal antibodies (mAbs) has been used to separate NDV isolates into 
specific antigenic groupings (Alexander et al., 1997). However, mAb binding tests 
have failed to differentiate viruses that were antigenically similar, although not 
genetically identical. In contrast, analysis of nucleotide sequences has allowed 
differentiation of even extremely closely related viruses resulting in important 
xiii 
 
epidemiological evidence of virus origin (Alexander et al., 1999). Nucleotide 
sequencing, after reverse transcription-polymerase chain reaction and phylogenetic 
analysis, has been used by a number of authors to assess genetic differences and 
genotypes of NDVs (Sakaguchi et al., 1989, Toyoda et al,, 1989, Seal et al., 1995, 
Collins et al., 1996, 1998, Seal et al., 1996, Lomniczi et al., 1998). In the 
preliminary characterization studies of NDV, six genoptypes (I to VI) were 
determined using restriction enzyme analysis (Ballagi-pordany et al., 1996). These 
grouping have subsequently been confirmed, and two further genotypes (VII and 
VIII) and several subtypes within this have been identified through nucleotide 
sequencing studies (Lomniczi et al., 1998, Seal et al., 1998, Herczeg et al., 1999, 
Yang et al., 1999, Cattoli et al., 2001, Herczeg et al., 2001, Ke et al., 2001, Yu et 
al., 2001). Currently, ten ND genotypes have been classified in the world (Tsai et 
al., 2004). It has been established that sequences of as little as 250 base pair give 
meaningful phylogenetic analyses, comparable with those obtained with much 
longer sequences (Seal et al., 1995, Lomniczi et al., 1998).  
In the Sudan, NDV was first reported in Khartoum in 1951 (Anon, 1951). Since 
then the disease has been regularly mentioned in all reports of the Sudan veterinary 
services. Diagnosis was based on the picture of disease, but the virus was isolated 
and identified for the first time in 1962 (Karrar and Mustafa, 1964 and Esia, 1979). 
According to Ballouh et al (1983), twelve NDV isolates obtained during 1963-
1979 in the Sudan were mesogenic (n=4) and velogenic (n=8). During the year 
1984-1985, four virus isolates were found to be velogenic (Haroun et al., 1992). In 
another study, six isolates were obtained from outbreaks in the country between 
1988 and 1991 and found to possess the characteristics of the viscerotropic 
velogenic strains of NDV [VVNDV] (Khallafalla et al., 1992). Khallafalla et al 
(1992) concluded that the VVNDV is the most prevalent pathotype in the Sudan. 
xiv 
 
Search of literature revealed 3 publications on phylogenetic analysis of NDV 
isolates from Sudan (Ujvári et al., 2003, Aldous et al., 2003 and Hassan et al., 
2009) that covered the period 1975- 2006. In the present study we genetically 
characterized two velogenic viscerotropic VDV isolates from the 1990 outbreaks 
and discussed the molecular epidemiology of the disease in Sudan.  
 
The aims of this study are: 
1. To genetically classify NDV isolates obtained between 1988 and 1999. 
2. To discuss origin and circulation of various NDV genotypes in the Sudan. 
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CHAPTER ONE 
REVIEW OF LITERATURE 
1.1 Newcastle disease 
1.1.1 Definition 
Newcastle disease (ND) is defined as a list A disease by the International 
Office for Epizootics (Office International des Epizooties, OIE) (Alexander, 
2001). Newcastle disease (ND) or avian paramyxovirus 1 infection 
(Alexander, 1997) is a viral disease of domestic poultry and wild birds. 
Gastrointestinal, respiratory and neurological signs of NDV infections of 
poultry range from inapparent to rapidly fatal depending upon the pathotype 
of virus involved (Alexander, 2003). The disease is highly contagious and 
affects over 250 species of birds of all age groups (Alexander et al., 1997). It 
causes high mortality (up to 100% in chickens) (Alexander 1997,1989).ND 
is caused by avian paramyxovirus serotype 1 (APMV-1) viruses which 
belong to the genus Avulavirus in the family Paramyxoviridae, order 
Mononegavirales (Mayo, 2002). The paramyxoviruses isolated from avian 
species have been classified by serological testing into nine serotypes 
designated APMV-1 to APMV-9 (Rima et al., 1995). 
According to the OIE (2000), ND is defined as follows: Newcastle disease is 
an infection of birds caused by a virus of avian paramyxovirus serotype 1 
(APMV–1) that meets one of the following criteria for virulence: the virus 
has an intracerebral pathogenicity index (ICPI) in day-old chicks (Gallus 
gallus) of 0.7 or greater or multiple basic amino acids have been 
demonstrated in the virus (either directly or by deduction) at the C-terminus 
of the F2 protein and phenylalanine at residue 117, which is the N-terminus 
of the F1 protein. The term ‘multiple basic amino acids’ refers to at least 
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three arginine or lysine residues between residues 113 to 116. Failure to 
demonstrate the characteristic pattern of amino acid residues as described 
above would require characterization of the isolated virus by an ICPI test. In 
this definition, amino acid residues are numbered from the N-terminus of the 
amino acid sequence deduced from the nucleotide sequence of the F0 gene, 
113–116 corresponds to residues –4 to –1 from the cleavage site (OIE, 
2000). 
 
1.1.2 History 
The first outbreaks to be recognized and termed Newcastle disease (ND) 
occurred in poultry in 1926, in Java, Indonesia (Kraneveld, 1926), and in 
Newcastle-upon-Tyne, England (Doyle, 1927). However, there are earlier 
reports of similar disease outbreaks in Central Europe before this date 
(Halasz, 1912). In particular, Macpherson (1956) attributed the death of all 
the chickens in the Western Isles of Scotland in 1896 as being due to 
Newcastle disease. It is possible; therefore, that ND did occur in poultry 
before 1926, but its recognition as a specifically defined disease of viral 
aetiology dates from the outbreaks during that year in Newcastle-upon-Tyne. 
The name “Newcastle disease”, (after the geographical location of the first 
outbreaks in Great Britain), was coined by Doyle as a temporary measure 
because he wished to avoid a descriptive name that might be confused with 
other diseases (Doyle, 1935). The name has, however, continued to be used 
although when referring to the ND virus (NDV), the synonym ‘avian 
paramyxovirus type 1’ (APMV-1) is now often employed. The pattern of 
outbreaks which are due to virulent NDV throughout the world suggest that 
several panzootics have occurred in poultry since 1926. The first appeared to 
have spread very slowly across the globe, apparently from the Far East. It 
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probably took over 20 years to become a true panzootic and probably never 
reached poultry in the USA. The beginning of the second ND panzootic was 
first recognized at the end of the 1960s and within four years had reached all 
corners of the earth (Hanson, 1972). The reasons for the different spreading 
rates of the two panzootics appear to be the development of the world 
poultry industry and the commercialization of poultry food production. 
Another ND panzootic occurred in the 1980s, but in racing and show 
pigeons (Columba livia) rather than in poultry. Infections in pigeons with 
this variant NDV strain probably began in the Middle East in the late 1970s 
(Kaleta et al., 1985), and by 1984-5 had become a true panzootic. In many 
countries where outbreaks occurred there was also spread to feral pigeons 
and doves. That virus was termed pigeon paramyxovirus-1 (PPMV-1) 
(Collins et al., 1989). 
 
1.2 Newcastle disease virus (NDV) 
1.2.1 Classification 
NDV is classified as a member of the order Mononegavirales, family 
Paramyxoviridae, subfamily Paramyxovirinae. It was initially considered as 
the prototype for the genus Paramyxovirus, but in 1993 it was placed within 
the genus Rubulavirus (Rima et al., 1995). Since the virus did not contain 
the small hydrophobic gene (Lamb and Kolakofsky, 1996) that is present in 
all of the other rubulaviruses, de Leeuw and Peeters (1999) suggested it be 
placed as a separate member of the Paramyxovirinae. In the current virus 
taxonomy, NDV or avian paramyxovirus type 1, is classified, with the other 
avian paramyxoviruses, in the genus Avulavirus, subfamily 
Paramyxovirinae, family Paramyxoviridae, order Mononegavirales (Lamb et 
al., 2000; Mayo, 2002). Based on the severity of disease produced in 
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chickens, NDV strains have been categorized into three main pathotypes: 
lentogenic, mesogenic and velogenic strains. Lentogenic strains are avirulent 
and may cause mild or inapparent respiratory infection. Mesogenic strains 
are of intermediate virulence and cause respiratory symptoms with low 
mortality, whereas velogenic strains are highly virulent and cause high 
mortality (Alexander, 1996).  
 
1.2.2 Virion properties 
Newcastle disease virus (NDV), a member of the paramyxovirus family has 
a helically symmetrical nucleocapsid, 600-800nm in length and 18 nm 
(Paramyxovirus, Rubulavirus, Morbillivirus) or 13 nm (Pneumovirus) in 
diameter and pleomorphic in structures (Murphy et al., 1999). Most of these 
are roughly spherical with diameters around 100 to 500 nm. Occasionally, 
filamentous particles of approximately 100 nm in diameter and variable 
length can be seen. The virion is enveloped with a lipid bilayer membrane 
derived from the host cell membrane. The virus contains three envelope and 
three core proteins (Bratt and Hightower, 1977; Choppin et al., 1981). 
Envelope proteins include a large glycoprotein with both haemagglutinin 
and neuraminidase activities (HN), a smaller glycoprotein with cell-fusing 
activity (F), and hydrophobic non-glycosylated protein (M) localised at the 
inner surface of the envelope. The haemagglutinin-neuraminidase (HN) and 
fusion (F) proteins appear as tiny spikes projecting from the external surface 
of the membrane when observed under an electron microscope. These 
relatively complex proteins interact with each other and are involved in viral 
infectivity and virulence (Stone-Hulslander and Morrison, 1997). Either of 
these proteins can induce protective immunity (Meulemans et al., 1986; 
Nagy et al., 1991). The matrix (M) protein, is not only associated with the 
5 
 
membrane but also with the N-terminal segment of the HN protein located in 
its inner surface (Garcia-Sastre et al., 1989). The M protein is believed to 
interact with the nucleocapsid (NP) that resembles the classical herringbone 
morphology that can be clearly seen when the viral membrane is removed or 
disrupted. This herringbone-like structure comprises thousands of NP 
subunits that are associated tightly with several copies of phosphoprotein (P) 
and large protein (L). The non-segmented, single-stranded negative-sense 
RNA genome of 15,186 nucleotides (nt) in length (Krishnamurthy and 
Samal, 1998; Phillips et al., 1998, de Leeuw and Peeters, 1999) is located in 
the central hollow of the herringbone-like nucleocapsid. Together, these 
three RNA-associated proteins and the RNA genome constitute the viral 
transcriptase complex. The interactions between these macromolecules and 
their binding domains have yet to be defined completely. 
 
1.2.3 Viral genome 
The RNA genome contains six major genes that encode the structural 
proteins in the order 3΄-NP-P-M-F-HN-L-5΄ (Chambers et al., 1986a; Wilde 
et al., 1986) as well as two non-structural proteins, W and V (Yusoff and 
Tan, 2001). These non-structural proteins may result from differential 
initiation (McGinnes et al., 1988), or transcriptional editing of the P gene 
mRNA (Steward et al., 1993). RNA sequencing studies revealed that the 3΄ 
and 5΄ ends of the genomic RNA respectively contain a leader sequence and 
a trailer sequence of some 50 nucleotides (Kurilla et al., 1985; Yusoff et al., 
1987). Transcription of the leader sequence results in the production of the 
leader transcript, which is the smallest but most abundant mRNA (Peeples, 
1988). Phillips et al (1998) showed that the trailer region of Beaudette C, a 
virus strain from USA, has 114 nucleotides. The 5΄ terminus of the trailer 
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sequence shares a high degree of complementarity with that of the 3΄ 
terminal leader sequence (Peeters et al., 2000). These sequences may be 
involved in the regulation of NDV replication, transcription and 
encapsidation of the genomic and antigenomic RNAs (Lamb and 
Kolakofsky, 1996). The six structural genes are separated by intergenic 
regions of variable lengths (1 to 47 nucleotides) which could be involved in 
terminating mRNA transcription from the preceding gene, before initiating 
transcription of the subsequent gene (Ishida et al., 1986; Millar et al., 1986; 
Yusoff et al., 1987; Phillips et al., 1998). At least eight species of mRNA 
transcripts are produced by the viral transcriptase complex, comprising the 
RNA genome, NP, P and L proteins. The largest of all, the genome 
complement RNA of the positive sense or antigenome, serves as the 
template for the synthesis of full length genomic RNA (Dues berg and 
Robinson, 1965). Direct transcription of the start signals (3΄-
UGCCCAUCU/CU-5΄) preceding the six major genes results in six mRNAs, 
which are capped, methylated and terminated at a common polyadenylation 
site (3΄-AA/UCUUUUUU-5΄) (Ishida et al., 1986; Millar et al., 1986; 
Yusoff et al., 1987). Unlike these mRNAs, the leader transcript is not 
capped, methylated or polyadenylated (Peeples, 1988). Transcriptional 
modification of the P gene mRNA, by insertion of one or two non-templated 
G residues at nucleotide position 484 in the P transcript, produces extra 
species of modified mRNAs (Steward et al., 1993; Locke et al., 2000) that 
encode non-structural proteins, V (+ one nucleotide frame shift) and W (+ 
two nucleotide frame shifts), respectively (Yusoff and Tan, 2001). 
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1.2.4 Fusion glycoprotein 
The F glycoprotein that mediates fusion of the viral and cellular membranes 
is synthesized as an inactive precursor, F0 , containing 553 amino acids with 
a calculated molecular weight of ~55 kDa (Chambers et al., 1986 b; Salih et 
al., 2000). The precursor is proteolytically cleaved at the peptide bond of 
residues 116 and 117, to generate two disulphide linked polypeptides, F1 (48 
to 54 kDa) and F2 (10 to 16 kDa) by specific cellular proteases (Gotoh et al., 
1992; Ogasawara et al., 1992). There is now evidence that the cleavability of 
F0 is a major determinant for virulence (Peeters et al., 1999). 
Unlike the HN, the transmembrane domain of the F glycoprotein, which 
anchors the protein in the membrane, is located near the C-terminus 
(residues 501 to 527) (Chambers et al., 1986 b). 
There are five to six potential glycosylation sites within the F glycoprotein, 
of which one is located on the F2 fragment and the rest are found on the F1 
fragment (Chamber et al., 1986 b; McGinnes and Morrison, 1986). 
However, no work has been carried out to determine which sites are indeed 
glycosylated. Amino acid sequence analysis of the F glycoprotein of NDV 
and other paramyxoviruses revealed a conserved hydrophobic region of 
some 20 residues located at the amino-terminus of the F1 fragment (Lamb 
and Kolakofsky, 1996). This region, known as fusion peptide or fusion 
sequence, is thought to participate directly in the fusion of viral and host cell 
membranes (Hernandez et al., 1996). In addition, three heptad repeats (HR 
a,b and c) , which can form a triple-stranded coil containing three α-helices, 
have been demonstrated to play an important role in fusion by mutational 
analysis (Buckland et al., 1992; Sergel-Germano et al., 1994; Reitter et al., 
1995). HRa is located immediately after the fusion peptide between amino 
acids 143 and 185 (Chambers et al., 1990), a region between amino acids 
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268 and 289 constitutes HRb (Sergel et al., 2000), and HRc is located 
adjacent to the transmembrane domain (Buckland and Wild, 1989). Both 
HRa and HRb seemed to be able to interact with each other and play an 
important role in the fusion mediated by the coexpression of the HN and F 
proteins (Young et al., 1997, 1999). Unlike that of the other 
paramyxoviruses, HRb seems to be virus specific and can only inhibit fusion 
if added to the virus prior to F0 cleavage (Young et al., 1999). HRb and HRc 
domains contain a leucine repeat (zipper) motif at every seventh position 
(Sergel et al., 2000). Unfortunately, there is no information available on the 
structure of the F glycoprotein to elucidate the three-dimensional location of 
these fusion regions and their synergistic functions in fusion activities 
(Yusoff and Tan, 2001). 
 
1.2.5 Characteristics of Newcastle disease virus  
One of the most characteristic properties of different strains of NDV has 
been their great variation in pathogenicity of chickens. NDV (APMV-1) may 
show some antigenic cross-relationship with some of the other avian 
paramyxovirus serotypes, particularly APMV-3 and APMV-7 (Alexander, 
1997). The incubation period varies with the strain of the virus, and 
generally is 4-5 days (rang 2-15 days). The virus, like most enveloped 
viruses, is considered heat labile and is inactivated by formalin, alcohol, 
lipid solvents, lysol and ultraviolet light (Bratt and Clavell, 1972). 
 
1.2.6 Host range 
NDV has a wide host range, infecting 27 of the 50 orders of birds (Jørgensen 
et al., 1998; Kuiken et al., 1998; Schelling et al., 1999; Alexander, 2000a). 
Probably, all avian species are susceptible to infection with APMV-1 
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viruses, but in addition to the variation in pathogenicity of different viruses 
the severity of disease is highly dependent on the avian host species thus 
waterfowl, although susceptible to infection, rarely show severe disease, 
while domestic fowl are highly susceptible to both infection and disease 
(Alexander, 1995). Most susceptible are domestic fowl, turkeys, pigeons, 
and parrots (Cross, 1991). Milder forms of the disease are seen in ducks, 
geese, pheasants, quail, guinea fowl, and canaries. Although waterfowl are 
readily infected, they usually show few or no clinical signs, even when 
infected with strains that are virulent in chickens, so waterfowl are 
considered a potential reservoir of NDV. Most animals like dogs, cats, foxes 
and rodents shed virus in their faeces for as long as 72 h after having eaten 
infected fowl carcases (White and Jordan, 1963). Thus, they can act as 
transient reservoirs of NDV due to their contact with village poultry and the 
village environment. Man can also be infected with NDV, showing mild 
signs of conjunctivitis and can shed virus (Beard and Hanson, 1984).  
 
1.2.7 Transmission 
NDV replicates in the intestine and may be transmitted by ingestion of 
contaminated faeces or by inhalation of small infective particles produced 
from dried faces (Alexander, 1997). 
Traditional’ routes of NDV transmission such as direct animal contact, 
contaminated feed, water, implements, transport contact or transmission by 
people have been identified (Alexander, 1988, 2003). Airborne transmission 
was also one of the important routes for spreading of ND. The success of 
this route of transmission will depend on many environmental factors, such 
as temperature, humidity, and stocking density.  
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Secondary spread during most epizootics of ND in recent times has been the 
result of the movements of personnel or equipment. Human beings may be 
infected with NDV, but their most likely role is the transfer of infective 
poultry faeces from one site to another via clothing, footwear, crates, feed 
sacks, egg trays or vehicles (Alexander, 2004). 
In the past, poultry meat has been seen as the main vehicle for the 
introduction and spread of NDV. Modern methods of poultry carcass 
preparation as well as legislation on the feeding of untreated swill to poultry 
have greatly diminished the risk from poultry products, but the possibility of 
spread in this way still remains (Alexander, 2004). 
 
1.3 Pathogenicity  
The pathogenicity of NDV strains varies greatly with the infected host 
(Higgins, 1971). In chickens the pathogenicity of NDV is determined chiefly 
by the strain of the virus, although doses, route of administration, age of the 
chickens and environmental conditions all have an effect (Alexander, 1991). 
 
1.3.1 Molecular basis of pathogenicity of ND 
NDV pathogenicity has been shown to be dependent on the amino acid 
sequence at the cleavage site of the F0 protein (Nagai et al., 1976a; 
Glickman et al., 1988; Long et al. 1988; Collins et al., 1993, 1994). The 
sequence of the cleavage site correlates with the pathogenicity of NDV 
strains. The cleavage is mediated by host cell proteases (Nagai et al. 1976a). 
Trypsin is capable of cleaving F0 for all NDV strains and in vitro treatment 
of noninfectious virus will induce infectivity (Nagai et al., 1976b). 
For the mesogenic and velogenic strains, the cleavage site consists of two 
dibasic residues separated by a single glutamine residue (111-Gly-Arg-Arg-
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Gln-Arg/Lys-Arg-116) and Phe at residue 117, whereas in the lentogenic 
strains there are fewer basic residues because those residues at positions 112 
and 115 are substituted by other amino acids (111-Gly/Glu-Gly-Lys/Arg-
Gln-Gly/ Glu-Arg-116) and Leu at residue 117. By subjecting the RT-PCR 
products of the F0 cleavage site and parts of the M gene to restriction 
enzyme analysis, it was possible to identify and differentiate the various 
NDV isolates (Ballagi- Pordány et al., 1996; Wehmann et al., 1997, 1999; 
Kuo et al., 1999; Gohm et al., 2000; Herczeg et al., 2001). Nanthakumar et 
al.(2000 a,b) could distinguish the lentogenic strains from the mesogenic 
and velogenic ones by this method where PCR products are digested with 
HinfI, BstOI and RsaI restriction endonucleases, respectively 
The presence of basic amino acids at positions 113, 115 and 116 and 
phenylalanine at 117 in virulent strains means that cleavage can be affected 
by protease or proteases present in a wide range of host tissues and organs. 
For viruses of low virulence, cleavage can occur only with proteases 
recognizing a single arginine, i.e. trypsin-like enzymes. Such viruses are 
therefore restricted in the range of sites where they are able to replicate to 
areas with trypsin-like enzymes, such as the respiratory and intestinal tracts, 
whereas virulent viruses can replicate in a wider range of tissues and organs 
resulting in a fatal systemic infection (Rott, 1979). 
 
1.4 The disease in the Sudan 
In the Sudan, NDV was first reported in Khartoum in 1951 (Anon, 1951). 
Since then the disease has been regularly mentioned in all reports of the 
Sudan veterinary services. Diagnosis was based on the picture of disease, but 
the viruses was isolated and identified for the first time in 1962 (Karrar and 
Mustafa, 1964; Esia, 1979). 
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According to the Ballouh et al (1983), twelve of the NDV strains were 
isolated from the country during 1963-1979. Eight of them were velogenic 
and four were mesogenic (Ballouh et al., 1983). During the year 1984-1985, 
four virus strains were isolated from outbreaks around Shambat, north of 
Khartoum (Haroun et al., 1992). In another study (Khallafalla et al., 1992), 
six strains were isolated from outbreaks in the country between 1988 and 
1991. All of these isolates were similar in that they killed chicken embryos 
quickly in MDT, embryo lethal dose 50 (ELD 50), had higher ICPI and 
characteristics of the viscerotropic velogenic strains of NDV (Khallafalla et 
al., 1992).  
According to phylogenetic analysis in Sudan, it can be proposed that 
genotype VI of NDV is present in Sudan since 1970s (Ujvári et al., 2003). 
Genotype IV contains the isolate BSDCK72176, a virus isolated from 
Sudanese fowls in 1991 (Aldous et al., 2003). It also contains the isolate 
Chicken/Sudan/Obied/87 isolated from Obied in 1987 (Hassan et al., 2009). 
Genotype VIId that was isolated from vaccinated immature and adult layer 
flocks in Khartoum State and eastern Sudan (Gadarif) between 2003 and 
2006 has been maintained by enzootic infection in recent years in Sudan and 
might have spread via a trade partner from Middle East (Hassan et al., 
2009).  
 
1.4.1 Seroepidemiology of ND in Sudan 
According to Abdelaziz (2001), it can be concluded that the prevalence of 
ND as measured by the sero conversion seemed to be higher in Gedarif area 
(East Sudan) compared to Khartoum (Middle Sudan), Eldamar (North 
Sudan) or Kordofan (West Sudan). 
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1.5 Diagnosis 
The diagnosis of ND requires a combination of techniques such as clinical 
signs and symptoms (gross and histological observations), virus isolation 
and serology.  
 
1.5.1 Clinical signs 
The clinical signs seen in birds infected with NDV vary widely and are 
dependent on factors such as: the virus, the host species, age of host, 
infection with other organisms, environmental stress and immune status. 
Infections with ND viruses can lead to a broad range of clinical signs, 
varying from asymptomatic enteric infections to systemic infections causing 
100% mortality. Using the clinical signs seen in experimental NDV 
infections of chickens, NDV strains have been divided into five groups 
(Beard and Hanson, 1984): 
1. viscerotropic velogenic(VV): highly virulent disease in which 
haemorrhagic lesions are characteristically present in the intestinal 
tract 
2. neurotopic velogenic(NV): high mortality following respiratory and 
nervous signs 
3. mesogenic(M): respiratory and nervous signs, but usually with low 
mortality 
4. lentogenic(L): a mild or inapparent infection of the respiratory tract 
5. asymptomatic enteric: an inapparent intestinal infection. 
 
In general terms, ND may consist of signs of depression, diarrhoea, 
prostration, oedema of the head and wattles, nervous signs, such as paralysis 
of the legs and wings or other neurological signs, and torticollis, the head 
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turned to one side ,and respiratory signs (McFerran and McCracken, 1988). 
Fall in egg production, perhaps leading to complete cessation of egg laying, 
may precede more overt signs of disease and deaths in egg-laying birds. 
Virulent ND strains may still replicate in vaccinated birds, but the clinical 
signs will be greatly diminished in relationship to the antibody level 
achieved (Allan et al., 1978). Other typical characteristics of the disease 
include: rapid spread; death within 2-3 days; a mortality rate of over 50 
percent in naïve populations; and an incubation period of 3-6 days or, on 
rare occasions, 2-15 days (Beard and Hanson, 1984). 
 
1.5.2 Lesions 
No gross or microscopic lesions can be considered pathognomonic for any 
form of ND (McFerrin and McCracken, 1988). Gross lesions vary with the 
infecting virus. Virulent panzootic ND viruses typically cause haemorrhagic 
lesions of the intestinal tract and may vary considerably in size. Some 
authors have reported lesions most typically in the proventriculus, while 
others consider them to be most prominent in the duodenum, jejunum and 
ileum. Even in birds showing neurological signs prior to death, there is 
usually little evidence of gross lesions in the central nervous system. Lesions 
are usually present in the respiratory tract when clinical signs indicate 
involvement. These generally appear as haemorrhagic lesions and 
congestion; airsacculitis may be evident. Egg peritonitis is often seen in 
laying hens infected with virulent NDV. Microscopic lesions are not 
considered to have any diagnostic significance. In most tissues and organs 
where changes occur, they consist of hyperaemia, necrosis, cellular 
infiltration and oedema. Changes in the central nervous system are those of 
nonpurulent encephalomyelitis (Alexander, 2004). 
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1.5.3 Virus isolation 
The definitive diagnosis of ND is done through isolation and identification 
of the virus (Alexander, 1998). Tracheal and cloacal swabs are good sources 
of virus for isolation from living birds without having to kill them. A cotton-
covered stick is inserted into the trachea or cloaca, and then put into a vial 
containing phosphate buffered saline plus penicillin and streptomycin. It is 
important to ensure that cloacal swabs are coated with faeces. These samples 
must be kept cool during transport to the laboratory where they should be 
stored at 4 ˚C if they are to be processed within 48 hours or frozen at least at 
-20 ˚C until the isolation attempt. Although cloacal swabs or faeces should 
always be sampled, virus can also be isolated from homogenised organs 
from dead birds, chosen to reflect the clinical signs. Nine-day-old 
embryonated chicken eggs are injected with 0.1mL of the suspension into 
the allantoic cavity and returned to incubation. The eggs are candled twice 
daily. As dead eggs occur, they are chilled, together with all eggs after 5-7 
days incubation, are chilled at 4 °C at which point the allantoic fluid is then 
harvested and tested for its ability to haemagglutinate chicken red blood 
cells. Diagnosis is based on the inhibition of haemagglutination by specific 
anti-NDV serum. This proves infection of the bird by the virus, but does not 
indicate whether the virus is a pathogenic or avirulent strain (Alexander, 
2004). 
 
1.5.4 Serological test  
Serological diagnosis has a limited value because of routine use of vaccines. 
In the absence of vaccination, the presence of specific antibodies against the 
ND virus indicates that the bird has been infected by the virus at some time, 
but not necessarily that it was suffering from the disease at the time of 
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sampling. In practice, a high antibody titre is indicative of a recent infection. 
Three methods are used to measure antibody titres: the haemagglutination 
inhibition (HI) test (the most widely used), the enzyme-linked 
immunosorbent assay (ELISA) and serum neutralization test (Alexander 
1996). 
 
1.5.5 Immunological diagnosis 
Direct detection of NDV can be achieved through immunohistochemistry, in 
situ hybridization and immunoperoxidase assay (Russell et al., 1983; 
Lockaby et al., 1993; Brown et al., 1999). However, the most widely used 
methods for NDV detection are routine serological tests such as virus 
neutralization and haemagglutination-inhibition (HI) assays (Alexander, 
1989). Although these tests are relatively inexpensive and simple to perform, 
they can be time consuming and may lack the required sensitivity when sera 
from other species are tested. Cross reactions often occur in HI and the 
results obtained are often non-reproducible when performed in different 
laboratories (Beard and Wilkes, 1985). In addition, virus neutralization 
requires the growth of the viruses in specific hosts or cell cultures.  
The indirect enzyme-linked immunosorbent assays (ELISAs) are now 
becoming more popular correlated to the HI tests (Brown et al., 1990; 
Cvelic-Cabrilo et al., 1992; Cadman et al., 1997; Schelling et al., 1999). 
They are more sensitive and specific than HI (Williams et al., 1997). 
Initially, the whole virus was used as coating antigen for NDV detection 
(Miers et al., 1983; Wilson et al., 1984, Jestin et al., 1989) but they were not 
able to discriminate naturally infected birds from those vaccinated as both 
antisera would bind to the whole virus. To achieve this, differential ELISA 
(Errington et al., 1995; Makkay et al., 1999) and mAb blocking ELISA 
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(Czifra et al., 1996) techniques were developed. These are more sensitive 
and specific than indirect ELISA and HI. Nevertheless, apart from HI, these 
tests are still the methods of choice in most laboratories for the detection of 
NDV.  
Direct or indirect complement fixation (CF) tests (Butterfield and Graves, 
1974). latex agglutination test (LAT) (Thirumurugan et al, 1997), agar gel 
immunodiffusion (AGID) and counterimmunoelectrophoresis (CIE) have 
also been used for detection and diagnosis of  ND (Roy and Venugopalan 
1997). 
Analysis of the binding patterns of a panel of monoclonal antibodies (mAbs) 
has been used to separate NDV isolates into specific antigenic groupings 
(Alexander et al., 1997). This system has proved useful for rapidly sorting 
viruses into broad groups, and the mAb groups described by Alexander et al 
(1997) have been used as adescriptive basis and separate NDV into 14 
different patterns groups (A, B, C1, C2, D, E, F, G&Q, H, L, J, P, NE, 
PORT). However, mAb binding tests have failed to differentiate viruses that 
were antigenically similar, although not genetically identical. 
 
1.5.6 Molecular diagnosis 
Molecular techniques that are based on nucleic acid technology and used in 
the diagnosis of NDV (reviewed by Aldous and Alexander, 2001) include 
nucleic acid hybridization with specific probes (Jarecki-Black et al., 1992; 
Jarecki-Black and King, 1993), viral genomic RNA fingerprint analysis 
(McMillan and Hanson, 1982; Palmieri and Mitchell, 1991), the use of 
antipeptide antibodies to pathotype specific regions on the HN and F 
proteins (Scanlon et al., 1999) and reverse transcription polymerase chain 
reaction (RT-PCR). However, no significant difference was detected 
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between sensitivity of histology, virus isolation, serology, and RT-PCR 
(Kuiken et al., 1999). 
An alternative method is to sequence the RT-PCR products (Collins et al., 
1993) but several sets of different primers were required for the different 
strains. Pathotype prediction was further improved using a set of degenerate 
primers (for the F0 cleavage site and the nuclear localization signal of the M 
protein) in a single-tube RT-PCR reaction coupled to direct DNA 
sequencing followed by phylogenetic analysis (Seal et al., 1995). This test 
was useful in the surveillance of velogenic strains (Berinstein et al., 1999). 
Similarly a single-tube multiplex RT-PCR has been developed to detect and 
distinguish between NDV and avian pneumovirus (Ali and Reynolds, 2000). 
General primers have been used to amplify the cleavage region of the F 
protein of different pathotypes of NDV (Kant et al., 1997; Oberdorfer and 
Werner, 1998; Gohm et al., 2000) performed a second, nested PCR 
involving pathotype-specific primers.  
Pathotype specific oligonucleotides were used by Oberdorfer and Werner 
(1998) to probe PCR products that had been spotted onto nitrocellulose, 
hybridization being revealed by colour generation. Aldous et al (2001) have 
also used pathotype-specific oligonucleotide probes, the hybridization taking 
place during the PCR reactions and being revealed by light emission. 
Problems of contamination, costs and logistics of these techniques make 
them difficult to use outside research laboratories, particularly by developing 
countries. To address these problems, a one tube nested RT-PCR technique 
was developed that is coupled with an ELISA-based colourimetric detection 
system to detect NDV (Kho et al., 2000). This system improves the 
sensitivity and specificity of diagnostic assays (Wilson et al., 1993; Lage et 
al., 1996; Britten et al., 1997; Shaio et al., 1997). The single tube used in 
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this test is not only time and cost saving but also reduces the chance of 
contamination. The sensitivity and specificity is enhanced by subjecting the 
PCR products to a second round of PCR with an internal set of primers 
(nested PCR). Instead of detection by agarose gel electrophoresis, which is 
simple but can be very tedious for high sample throughput, an alternative 
colourimetric detection method involving the use of biotin avidin peroxidase 
was used. Samples can simply be analyzed visually or in an ELISA reader; 
this technique was more sensitive than gel electrophoresis or the HI test. 
According to nucleotide sequencing and phylogenetic analysis of the fusion 
protein gene, NDV is divided in to nine (sometimes ten) genotype (I–X) 
(Tsai et al (2004), Liu et al (2003), Lien et al (2007), Xu et al (2008), Liu et 
al (2008 a, b). 
In another type of grouping based on the region encoding the cleavage 
activation site and signal peptide of the fusion protein gene, Aldous et al 
(2003) divided NDV isolates into six broadly distinct groups (lineages 1 to 
6). Lineages 3 and 4 were further subdivided into four sublineages (a to d) 
and lineage 5 into five sublineages (a to e). 
Genotype I (lineage 1) are avirulent isolates, which include representative 
from those in mAb groups C2, L, G and H (Aldous et al., 2003), these 
viruses are often isolated from feral waterfowl throughout the world and 
were generally isolated world wide from 1967 to 2000. 
Genotype II (lineage 2) consist primarily of viruses that had origins in North 
America, isolated world wide from 1945 to 2000, varying from virulent 
isolate to those which induce only mild respiratory signs in chickens. Most 
of these viruses are widely used as live vaccines throughout the world, and 
this was reflected in the wide geographical distribution of the isolates 
forming genotype II having chickens and ostriches as their main hosts. 
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Genotype III (sublineage 3a) contains the ancient isolates from Australia, 
Europe and Asia from 1932 to 1999 along with highly virulent isolates, 
chicken was the main host.  
Genotype IV (sublineage 3b) were obtained between 1933(Herts/33) and 
1989, and form two divergent branches. The first contains ancient isolates, 
which originate from a diverse rang of countries in Europe, Africa, and Asia. 
The second contains viruses from Italy isolated between 1960 and 1987, and 
also includes the virulent Texas isolate.  
Genotype V (sublineage 3c) was largely composed of isolates derived from 
or considered to be from the second NDV panzootic in the 1970s 
(Alexander, 2001), which was influenced by trade in exotic birds and have 
three branches. The first is composed of cormorant viruses isolated between 
1975 and 1997.The second contains viruses mainly of European origin, 
isolated between 1972 and 1987. The third branch contains viruses from 
Tanzanian ducks, and an isolate from Tanzanian chicken purported to show 
mAb group G binding.  
Genotype VI (lineage 4) has been shown to be characterized by frequent 
branching and repeated epizootics caused by molecular variants separated by 
only short evolutionary intervals (Lomniczi et al., 1998). Subtype VIa 
(sublineage 4a) includes mainly ancient isolates originating in the Middle 
East epizootics in the 1960s, Africa and Europe from 1968 to 1996, included 
virulent isolates and chicken and falcon are the main host. Subtype VIb 
(sublineage 4b) is comprised solely of viruses associated with the ongoing 
panzootic in pigeons. All isolates belong to mAb group P. These pigeon 
isolates can be broadly separated into three clusters: The first includes 
mainly pre 1996 UK isolates, the second includes other European viruses 
isolated before 1998, and the third contains European viruses isolated since 
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1995. Subtype VIc (sublineage 4c) is composed of isolates originating from 
the Middle East, more specifically the United Arab Emirates and Saudi 
Arabia and Europe from 1989 to 1999 as velogenic strains in chickens and 
falcon. This group is composed solely of mAb B isolates. Subtype VId 
(sublineage 4d) contains virulent isolates that separate into two clusters: The 
first includes isolates from Europe and the second isolates of Asian origin 
between 1989 to 1999 in chickens, pigeons and Ostriches. Subtype VIe 
(sublineage 4a) strain contains the warwick/66 strain, which was isolated 
from an outbreaks in fowl in Great Britian in 1966 (Aldous et al., 2003). 
This subtype has shown a maximum divergence of 6.8% from VIa isolates. 
Subtype VIf and VIg, the VI subgenotype NDV endemic in Korea and China 
in the 1980s and 1990s was considered to belong to more ‘‘modern’’ VIf 
and VIg subgenotype (Kwon et al., 2003; Liu et al., 2003) were distinct 
from previously reported members of genotype VI. Only recently a 
‘‘modern’’ VIg subgenotype strain (TW99-154) was isolated in 1999 in 
Taiwan (Ke et al., 2001). Subtype VIh and X demonstrate a novel genotype 
X and a provisory subgenotype VIh present in Taiwan at least between 1969 
and 1980s composed solely of mAb C1.  
Genotype VII divided into five distinct subtypes as follows: Subtype VIIa 
(sublineage 5a) consists predominately of velogenic isolates originating 
from Europe, all being submitted between 1988 and 1996. Subtype VIIb 
(sublineage 5b) form four further distinguishable clusters. The first is 
composed of isolates mainly originating from Europe since the mid-1990s. 
The second cluster is composed of isolates originating from mainly South 
Africa and Mozambique from the mid-1990s. The third, much smaller, 
cluster is composed of three Portuguese isolates with type J mAb grouping, 
and a single putative mAb group F Bulgarian isolate, all isolated between 
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1993 and 1998. The remaining isolates from 1982 to 1994 are more diverse 
and are from Asia, America and Europe. Subtype VIIc (sublineage 5c) can 
be divided into two further groups: one composed mainly of velogenic 
isolates originating from Taiwan between 1984 and 1999, and the other 
comprising isolates from Europe in 1996/1997. Subtype VIId (sublineage 
5d) contains velogenic isolates from Asia and Middle East 1997 to 2000. It 
can be divided into two groups. The first contains isolates from Taiwan, all 
obtained since 1998. The other group contains viruses that were probably 
isolated during the same period, although little information is available. 
Subtype VIIe (sublineage 5e) isolated in Taiwan during 1994 to 1995, UK in 
1997 and from china in 2003. 
Genotype VIII (lineage 3d) is also composed of Velogenic isolates 
originating from many countries in Africa, Europe, and Asia and their years 
of isolation range from 1965 to 1994. It includes clusters from South Africa 
and Italy.  
Genotype IX novel genetic groups were the first Chinese virulent NDV 
strains isolated in china 1948, it was a unique genotype were still found 
inducing sporadic infections in certain areas. 
 
1.5.7  Pathogenicity tests (Pathotype) 
Due to lack of characteristic clinical signs, it is usually necessary for 
confirmed diagnosis to involve two steps: (i) isolation of the virus from 
affected birds and identification of the virus as NDV; and (ii) establishment 
of the virus as fulfilling a predetermined definition of ND that would 
distinguish it from vaccine viruses or avirulent enzootic ND viruses. This 
latter step usually involves an in vivo estimation of pathogenicity for 
chickens such as: 
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1-Intracerebral pathogenicity index (ICPI) in 1-day-old chicks. This involves 
the inoculation of virus derived from fresh infective allantoic fluid into the 
brain of ten day-old chicks from specific pathogen-free parents. Each bird is 
examined at 24-hour intervals for 8 days and graded zero if normal, one if 
sick and two if dead. The index is the mean score per bird per observation 
over the 8-day period. The most virulent viruses give ICPI values 
approaching the maximum score of 2.0, while lentogenic viruses give values 
of, or close to, 0.0 (Alexander, 1990). 
2-The intravenous pathogenicity index (IVPI) in 6-week-old chickens. Each 
bird is examined at 24-hour intervals for 10 days and scored: zero if normal, 
one if sick, two if paralyzed and three if dead. The index is the mean score 
per bird per observation over the 10 days period. The most virulent viruses 
give IVPI values approaching 2.0 and 3.0 while lentogenic and most 
mesogenic viruses will have IVPI values of 0.0 (Alexander, 1990). 
3-The mean death time in eggs (MDT). This involves inoculation of at least 
9-10 day old chicken embryos (Alexander, 1988). The MDT has been used 
to group NDV strains and isolates into three categories: velogenic (MDT 
less than 60 hours),  mesogenic (MDT 61 -90 hours) and lentogenic (MDT 
greater than 90 hours) (Alexander,1990). 
4-In the United States the intracloacal inoculation pathogenicity test is used 
to distinguish viscerotropic velogenic NDV from neurotropic velogenic 
viruses (Alexander, 1997, 1989).  
Although conventional diagnosis has proven adequate for the control of ND 
in the past, it does present some problems. Confirmed diagnosis may be 
slow, taking several days to isolate the virus and carry out the pathogenicity 
test. Identification of the virus as NDV and an estimate of its pathogenicity 
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also give no information that would enable assessment of the source of the 
virus and its spread (Collins et al., 1994). 
To differentiate virulent from avirulent strains of NDV by criteria other than 
pathogenicity included studies of variation of plaques in cell culture 
(Estupinan, and Hanson, 1971, Schloer, and Hanson, 1968) growth kinetic 
studies (Kendal, and Allan, 1970.), neuraminidase activity (Alexander, et 
al.1970), cell fusion (Kohn, and Fuchs, 1969), hemagglutination (HA), 
hemagglutination-elution tests (Kendal, and Allan, 1970, Spalatin, et 
al.1970). 
 
1.6 Vaccination  
1.6.1 Inactivated vaccine  
Inactivated vaccines are produced by growing ND virus in eggs, and then 
treating the infective allantoic fluid with an inactivating agent, such as 
formalin or betapropiolactone. An adjuvant, such as mineral oil, is usually 
then added to make the inactivated virus more immunogenic. Since the 
vaccine is no longer capable of replication or spread, it has to be injected 
individually into every bird needing vaccination. Inactivated vaccines 
produce very high levels of antibodies against NDV, and provide good 
protection against the virulent virus. In intensive poultry production, 
inactivated vaccines are usually applied after an initial priming vaccination 
with a live vaccine. In village poultry, however, good results in the absence 
of an initial vaccination with live vaccine have been reported (Bell et al., 
1990). The reason for this is probably, as serological surveys have shown 
(Bell and Mouloudi, 1988), that antibodies to the virus are already present in 
the village poultry as a result of previous infection by the wild virus. 
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1.6.2 Live vaccine 
Live vaccines differ from inactivated vaccines in that they can replicate in 
the host. The advantage is that it is not necessary to vaccinate every bird 
individually; and the disadvantage is that, since an infection with a live virus 
is involved, this may result in clinical signs and the severity of this reaction 
depends therefore on the particular vaccinal strain used (Westbury et al., 
1984) and the presence or otherwise of concurrent infection with other 
pathogens. Another advantage of live vaccines compared to inactivated 
vaccines, is their ease of application as they can be applied to the drinking 
water or with an eye-dropper. The majority of live vaccines are derived from 
asymptomatic enteric or lentogenic strains, although some vaccines derived 
from mesogenic strains are still in use (Alexander, 2004). 
 
1.6.3 Recombinant vaccine 
NDV has two surface glycoproteins, fusion [F] and haemagglutinin/ 
neuraminidase [HN]. The genes coding for either of these can be inserted 
into a different kind of virus to make a recombinant vaccine (Morgan et al., 
1993). One advantage of this technique is that the host virus may have better 
stability than NDV. Another advantage is that antigens for multiple different 
pathogens can be inserted into the same host virus to produce a single 
vaccine against several different diseases. Perhaps the most significant 
advantage for field use is that it is possible to monitor the response to the 
vaccine independently of the wild virus but in its presence, and conversely, 
it is possible to detect antibodies against the wild virus in the presence of 
vaccination. This is done by using an enzyme-linked immunoabsorbent 
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assay (ELISA) that uses a purified antigen, and comparing the results with 
those of an ELISA using a whole virus antigen (Makkay et al., 1999). 
Adisadvantage of recombinant vaccines is that where they have been 
developed commercially the cost is high. 
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CHAPTER TWO 
MATERALS AND METHODS 
 
2.1 Virus Strains 
Lasota strain 
Lasota vaccine strain was a live vaccinal strain obtained as freeze-dried 
ampoules of 1000 dose produced by Intervet Company, The Netherlands. It 
was used in this study as a control strain for propagation in chicken 
embryonated eggs and subsequent steps. 
I2 strain 
This strain was a live lentogenic thermostable NDV vaccinal strain 
propagated at the Central Veterinary Research Laboratory (CVRL) and 
produced as freeze–dried ampoules containing I2 seed virus. The I2 strain 
was originally isolated in Australian Center for International Agriculture 
Research (ACIAR). It was used in the present study as a control strain for 
propagation in chicken embryonated eggs and subsequent steps. 
Clone 30 
This was a live vaccinal strain prouduced by Intervet Company, the 
Netherlands and produced as freeze-dried ampoules of 1000 dose. The 
vaccine virus was propagated in embryonated chicken eggs. 
Dongola 88/1 strain 
This was a local isolate of lentogenic NDV, which was isolated in 1988 from 
apparently healthy chickens in Dongola city of Northern Sudan (Khalafalla, 
1994). 
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GD.S.1 strain 
This local field isolate of NDV strain was isolated from an outbreak that 
occurred in El soufi villages, 10 km from Gedarif city in June 1999 
(Abdelaziz, 2001) 
TY-1/90 
This local isolate of a visceroptropic velogenic NDV was isolated from an 
outbreak that occurred in Tayba city, 30 Km south of Khartoum in July 1990 
(Khalafalla et al., 1992). 
Dik-90 
This local isolate of visceroptropic velogenic NDV was isolated from an 
outbreak that occurred in Dikheinat city, 15 Km south of Khartoum in 
September 1990 (Khalafalla et al., 1992).  
 
2.2 Propagation and Harvest of NDV 
2.2.1 Source of eggs: 
All strains of NDV were grown in embryonated eggs, which were used for 
virus isolation, and antigen production for serological tests. Embryos used 
were usually obtained from the poultry farm of the Department of 
Microbiology, Faculty of Veterinary Medicine University of Khartoum. The 
flock of chicken reared in the farm was healthy and free from ND and other 
infectious disease. The eggs used were clean, fertile, and viable after 
candling prior to inoculation. They were first washed with 70% alcohol and 
were then placed in an incubator. 
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2.2.2 Incubation of eggs before inoculation 
Eggs were incubated at temperature of 38⁰ C to 39⁰ C. The humidity inside 
the incubator was maintained at 60 to 65%, using a tray filled with water and 
placed in the bottom of the incubator. The eggs were placed in the incubator 
with the air sac on top and were turned three times a day. 
 
2.2.3 Determining the viability of the embryo 
Candling was performed prior to and after inoculation using an electric 60 
W lamp housed in a box that contained a side hole to allow the light out of 
the box. Candling was performed by placing the eggs in front of the light 
whole and the following criteria were used to judge on the eggs and the 
embryos:  
Infertile eggs: These were easy to be detected, as the egg looked clear. 
Infertile eggs were discarded 
Early deaths: When the embryo developed for several days and then died, a 
small dark area could be revealed by candling and blood vessels looked 
disrupted. Often deteriorating blood vessels appeared as a dark ring around 
the egg. These were discarded. 
Late Deaths: These were often difficult to tell without a comparison with a 
viable embryo at the same stage of development. Absence of movement and 
the breakdown of the blood vessels should be looked for.  
Viable Embryos: When embryos are viable, they move in response to the 
light and have well defined blood vessels.  
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2.2.4 Inoculation of embryonated eggs  
Embryonated eggs at 9- or 10-days old were first candled to check the 
viability of the embryo and to mark the inoculation sites in the allantoic 
cavity. Eggs were then placed in a rack with the inoculation site at the top. 
The inoculation sites were then cleaned using cotton wool and 70% ethanol 
and the alcohol was allowed to evaporate. The eggshell punch was swabbed 
with 70% ethanol and the used cotton wool was placed in a discard tray. A 
hole was pierced in the end of the egg at the marked inoculation site using a 
needle attached to a 1 ml syringe. The inoculum, which must be free of 
microbial contamination, was drawn into a 1 ml syringe. The needle and the 
syringe were kept vertical and the needle was gently inserted through the 
hole in the eggshell. Approximately 16mm were needed to be penetrated by 
the needle into the egg for the allantoic cavity to be reached. A volume of 
0.1 ml of inoculum was injected into the egg. The needle was withdrawn 
from the egg and the hole in the shell was sealed with melted wax. The used 
needles and syringes were then discarded and the inoculated eggs were 
placed into incubator. 
 
2.2.5 Incubation of eggs after inoculation 
Inoculated eggs are incubated under the same conditions as un-inoculated 
eggs but they were not turned. 
 
2.2.6 Harvesting and storage of allantoic fluid 
Allantoic fluid from inoculated eggs were harvested on the 5th day after the 
incubation to be tested for the presence or absence of NDV by the 
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haemagglutination test prior to RNA isolation and RT-PCR test. Eggs were 
chilled at 4⁰ C for at least two hours for the embryo to be killed and to 
reduce the contamination of the allantoic fluid with blood during harvesting. 
The wax used to seal the egg was removed and each egg was swabbed with 
cotton wool soaked in 70% ethanol to disinfect and remove condensation 
from the shells.  The forceps (or scissors) were dipped in absolute alcohol 
and flamed to sterilize. Under sterile conditions, the eggshell above the air 
space was removed. Embryos that were visibly contaminated were 
discarded. A sample of allantoic fluid from each egg was removed using 
sterile 5 ml syringes without needles. Each sample was tested for the 
presence of Newcastle disease virus by the haemagglutination (HA) test 
(Section 2.3) and embryos that were HA negative for NDV were discarded. 
The fluid were collected into sterile containers and kept in a refrigerator.  
 
2.3 Testing of NDV Harvest 
2.3.1 Preparation of materials for the test 
2.3.1.1 Collection and washing of chicken red blood cells 
Blood was collected from the wing vein of healthy 3-6 weeks old chicken. It 
was mixed gently with the anticoagulant ethylenediamine tetra acetic acid 
(EDTA). After collection of the blood, RBCs were washed using sterile 
phosphate buffered saline (PBS). First the blood was transferred to a 
container suitable for centrifugation. Sterile PBS was added to fill the 
container. Then it was mixed gently and centrifuged at 1000 rpm for 10 
minutes and the supernatant were removed. This procedure was repeated 
three times and packed cells were then diluted to 1% for use in HA  
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2.3.1.2 Preparation of control samples of allantoic fluids 
Negative and positive control samples were tested in the rapid 
haemagglutination tests to ensure the validity of the test. Negative control 
allantoic fluid was harvested from 14-day old embryonated eggs that have 
not been inoculated with Newcastle disease virus. It should always test 
negative for the presence of haemagglutinins and there should not be any 
signs of haemagglutination. Positive control allantoic fluid is known to 
contain a high infectivity titre of Newcastle disease virus. It should always 
test positive for the presence of haemagglutinins and haemagglutination 
should be visible. 
 
2.3.1.3 Hyperimmune serum  
Undiluted hyperimmune serum (HIS) was kindly supplied by Prof. 
Khalafalla, Department of Microbiology, Faculty of Veterinary Medicine, 
University of Khartoum. It was produced in chickens against K-strain of 
NDV. 
 
2.3.2 Rapid haemagglutination test (HA) 
The presence of a haemagglutinating agent can be determined in one minute 
by this test. Three separate drops of 1% suspension of washed chicken RBCs 
were placed onto a white tile. One drop of the control and test samples were 
added to each drop of blood as follows: Using separate pipette tips, or a 
flamed loop, for each sample to be dispensed, the following were added: 
Drop 1 Negative control allantoic fluids (no haemagglutinin) 
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Drop 2 Positive control allantoic fluid (contains haemagglutinin) 
Drop 3 Unknown samples of allantoic fluid to be tested for the presence of 
NDV. The tile was rotated for one minute to mix. Results were observed and 
recorded.  Those of the test samples were compared with the ones of the 
control samples. Results of this test could be interpreted as follows: 
Agglutinated RBCs in suspension have a clumped appearance distinct from 
non-agglutinated RBCs. The RBCs, which were mixed with the positive 
control allantoic fluid should be clumped within one minute. The RBCs, 
which were mixed with the negative control allantoic fluid should remain in 
an even suspension and not clump. The results of the test sample were 
judged by comparison with the positive and negative controls whereby 
negative allantoic fluid control was also used to detect clumping of the red 
blood cells in the absence of virus, an event that is usually unlikely to occur.  
 
2.3.3 haemagglutination inhibition test (HI)  
The HI test is a convenient and commonly used assay that requires cheap 
reagents. The test was preformed to confirm that the hemagglutination 
ability of the allantoic fluid was due to NDV. With sterile pipette a drop of 
allantoic fluid under test was transferred to white tile and equal amount of 
known NDV hyperimmune serum was added, the tile was rotated gently and 
left for 5 minutes for the antibodies to bind to the haemagglutinin protein in 
the envelope of the virus. This blocks the haemagglutinin protein from 
binding with the receptor site on chicken red blood cells. After that, a drop 
of 1% suspension of washed red blood cells was added to white tile rotated 
gently and examined after one minute.  
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2.4 Primer Design 
Primers were designed from conserved nucleotide regions of the NDV 
fusion protein gene (F-gene). First, sequences of the NDV F-gene of various 
isolates of NDV were retrieved from the GenBank® 
(http://www.ncbi.nlm.nih.gov/Genbank/index.html) and were used for 
multiple sequence alignment to determine conserved regions in the F-gene. 
Second, conserved regions in the sequences were selected and primers were 
manually designed from these regions as shown in Table 1. The position of 
the three designed primers within the F-gene is shown in Fig. 1. Primers 
were sent for manufacture to 1st BASE Company, Singapore. 
 
Table 1. Primers designed and used in this study 
Name Sequence Length Position Tm Product size 
NCD_F1 CAG GCC TCT TGC AGC TGC 18 102-119 58 1412 
NCD_F2 TGG CAG TTG GGA AGA TGC A 19 530-548 58 984 
NCD_R TAT AGG TAA TGA GAG CAG ACG 21 1513-1493 58  
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Figure (1). The location within the NDV fusion protein gene of forward (NCD-F1 and 
NCD-F2) and reverse (NCD-R) primers designed and used in this study 
 
2.5 RNA extraction 
NDV RNA was extracted from harvested virus in chicken embryonic 
allantoic fluid using Roti®-Quick-Kit (Roth, Germany) according to the 
manufactures’ instructions. Briefly, 200 µl of allantoic fluid were mixed 
with 0.5 ml solution-1 in an Eppendorff tube. A volume of 0.65 ml of chilled 
(4⁰ C) solution-2 was then added and vortexed thoroughly and the tube was 
incubated on ice for 10 min. It was then centrifuged at 10000 rpm for 15min 
at 4⁰ C using a microcentrifuge (DJB Labcare Ltd, England). The upper 
aqueous layer (~0.5 ml) was pipetted into a fresh Eppendorff tube and 0.5 ml 
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of solution-3 was added to this. The solution was left to incubate at 20⁰ C 
for 40 min and was then centrifuged as above. The supernatant was removed 
and the RNA-pellet was resuspended in 150 µl solution-1 and 150 µl 
solution-3 and was incubated at 20⁰ C for 30 min. RNA was sedimented by 
centrifugation at 13000 rpm for 20 min at 4⁰ C. The RNA-pellet was washed 
twice in 0.5 ml of 70% ethanol by centrifugation at 13000 rpm for 3 min. 
Finally, RNA pellet was dissolved in 15-20 µl DEPC-treated autoclaved 
distilled water and was immediately used in RT-PCR. 
 
2.6 One Step RT-PCR 
RT-PCR was performed using QIAGEN® OneStep RT-PCR Kit (Qiagen, 
Germany). Primer stock solutions of 100 µM were first prepared then 
working dilutions of 10 µM were used in the RT-PCR reactions. Briefly, 
NDV RNA samples, primers, dNTP mix, 5x OneStep RT-PCR Buffer, Q-
solution and RNase-free water are thawed and placed on ice. All 
components required for RT-PCR are contained in the typical master mix 
except the template RNA. The master mix was prepared on ice as follows: 
- 6 µl RNase-free water. 
- 5 µl of 5x QIAGEN OneStep RT-PCR Buffer. 
- 5 µl of Q-solution. 
- 1 µl of dNTP mix (containing 10 µM each dNTP). 
- 1 µl primer F1 (or 1 µl primer F2). 
- 1 µl primer R. 
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- 1 µl of QIAGEN one step RT-PCR enzyme mix. 
Five microliters of RNA were added to each 20 µl of mastermix in a PCR 
tube. A negative control (without template RNA) was included in every 
experiment. The tubes were incubated in a thermal cycler (Primus96, Peqlab 
Biotech, Germany) and the RT-PCR program was carried out with the steps 
shown in Table 2. RT-PCR program was started while PCR tubes were still 
on ice and PCR tubes were placed in the thermal cycler when the latter 
reached 50⁰ C. 
 
Table 2. Thermal cycler program for Qiagen OneStep RT-PCR 
Step Time Incubation temperature 
Reverse transcription 20 min 50⁰ C 
Initial PCR activation step (to activate Hot 
Star Taq DNA polymerase) 
15 min 95⁰ C 
   
3 step cycling (x25-40)   
Denaturation 30 s 95⁰ C 
Annealing 32 s 50-68⁰ C 
Extension 40 s 72⁰ C 
   
Final extension 2 min 72⁰ C 
Steps for both reverse transcription and PCR are included in the typical thermal cycler program.  
 
Analysis of PCR product: 
The PCR products were separated electrophoretically in 2% agarose gel 
(Sigma, UK) in Tris/Boric acid/EDTA running buffer (TBE buffer). Agarose 
gel was prepared by dissolving 1 g of agarose in 50 ml of TBE buffer. 
Ethidium bromide (1µl /40 ml agrose) was added and the gel was casted into 
the tray, combs were placed and the gel inside the tray was allowed to 
solidify for 30 min. 5 µl of the PCR products were mixed with 1 µl of 6X 
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loading dye and transferred into the wells. Two microliters of 1 Kb DNA 
ladder (GeneRuler™ 1kb DNA Ladder Plus #SM1331, Fermentas, 
Germany) was loaded into the first well of the gel. The gel was allowed to 
electrophoerese for 45 min (120V and 30 mA), then DNA was visualized 
under UV light and the picture was documented using a gel documentation 
system (Bio-Rad, England) 
 
2.7 Sequencing 
PCR products were sent for commercial sequencing to MWG-Biotech AG 
Company, Germany).  
 
2.8 Phylogenetic analysis 
Editseq was used to edit the sequences before forward and reverse sequences 
of each strain were joined into one sequence using the sequence assembly 
software Seqman (Lasergen, DNAstar, US).  
Multiple sequence alignment was performed using ClustalW 
(http://clustalw.ddbj.nig.ac.jp/top-e.html) and phylogenetic and molecular 
evolutionary analyses were conducted using MEGA version 4 (Tamura et 
al., 2007). Genetic distances were calculated with the Kimura 2 parameter 
model (Kimura, 1980). 
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CHAPTER THREE 
RESULTS 
 
3.1 Virus propagation and identification 
All strains I2, LASOTA, CLONE 30, TY-1/90, DIK-90, GD.S.1, and 
DONGOLA were inoculated in the allantoic fluid of 9-day-old embryonated 
chicken eggs for NDV propagation. The Strains TY-1/90 and DIK-90 grew 
readily in embryonated eggs and the inoculated embryos died with 
haemorrhages in various organs in 2 to 3 days. The other strains failed to 
show any signs of death in embryonated chicken eggs. 
The presence of hemagglutinating agents was analyzed by the 
hemagglutination (HA) assay. All strains were positive in the 
hemagglutination test using 1% chicken red blood cells, and were also 
positive in haemagglutination inhibition test (HI). All the strains were saved 
as infected allantoic fluid stocks. 
 
3.2 RNA extraction  
For sequence analysis total RNA was extracted from allantoic fluids of 
embryonated eggs infected with NDV strains. The integrity and size 
distribution of total RNA were checked by denaturing agarose gel 
electrophoresis and ethidium bromide staining. The RNA bands appeared as 
sharp bands on the stained gel indicating that the RNA samples did not 
suffer major degradation during preparation. 
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3.3 Reverse Transcription Polymerase Chain Reaction (RT-PCR)  
Following RNA isolation, RNA from all the strains was reverse transcribed 
then amplified in a one step RT-PCR reaction to confirm NDV identity and 
to achieve molecular characterization analysis. The two sets of gene specific 
primers used in this study (Table 1) were able to amplify fragments with the 
expected sizes of 984 and 1412 bp respectively from the NDV fusion protein 
gene. Examination of the amplified PCR products following electrophoresis 
on agarose gels revealed the expected sizes of amplicons for NDV isolates. 
Figure (2) shows the results of RT-PCR amplification for detection of fusion 
protein gene of NDV strains by F1/R primer combination, which gave a 
PCR product size of 1412 bp. Figure (3) shows the results of RT-PCR 
amplification for detection of fusion protein gene of NDV strains by F2/R 
primer combination, which gave a PCR product size of 984 bp. 
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Figure (2). RT-PCR amplification of the Newcastle disease virus fusion protein gene 
using F1 (forward) and R (reverse) primer combination, which gave a product size of 
1412 bp. The amplicons were electrophoeresed in 2% agarose gel. Lanes: M, molecular 
size marker; Lanes 1-7 are NDV strains I2, TY-1/90, C30, Dik-90, GD.S.1, Lasota and 
Dongola, respectively; Lane 8, –ve control (H2O). 
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Figure (3). RT-PCR amplification of the Newcastle disease virus fusion protein gene 
using F2 (forward) and R (reverse) primer combination, which gave a product size of 
984 bp. The amplicons were electrophoeresed in 2% agarose gel. Lanes: M, molecular 
size marker; Lanes 1-7 are NDV strains I2, TY-1/90, C30, Dik-90, GD.S.1, Lasota and 
Dongola, respectively; Lane 8, –ve control (H2O). 
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3.4 Sequencing and sequence alignment 
Sequencing of the fusion protein gene of I2, LASOTA, CLONE 30, TY-
1/90, DIK-90, GD.S.1, and DONGOLA strains using the NCD_F2 forward 
and NCD_R reverse primers resulted in readable sequences that varied in 
length between 906-1002 nucleotides. For the purpose of accurate alignment 
data, all the sequences were reduced to an equal length of 894 nucleotides. 
This length covered the region between nucleotide numbers 588 and 1481 of 
the whole coding sequence (1662 nucleotides) of the fusion protein gene.  
The sequence alignment performed for I2, LASOTA, CLONE 30, TY-1/90, 
DIK-90, GD.S.1, and DONGOLA is shown in Figure (4). The alignment 
showed that all the sequences were identical in 759 nucleotides (84.9%), 
while differed from each other in 135 nucleotides (15.1%). The alignment 
showed that the sequences were grouped into two groups according to the 
number of identity a group contained strains TY-1/90 and Dik-90 and a 
group contained the rest of the sequences. Strains TY-1/90 and Dik-90 
showed a high degree of identity among themselves as 885 out of 894 
(98.99%) nucleotides were similar. The identity degree between the other 
five sequences was 100% in this 894 alignment length. 
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Figure (4). Nucleotide sequence alignment of the fusion protein gene of I2, LASOTA, CLONE 30, TY-1/90, DIK-90, GD.S.1, and 
DONGOLA Newcastle disease virus (NDV) strains. The alignment covered the region between nucleotides number 588 and 1481 of 
the coding sequence of the gene. Regions of similarity in the sequences were marked with stars, while regions of differences were not. 
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3.5 Phylogenetic analysis of fusion gene 
To assess the genetic lineage of the NDV strains used in this study, 
phylogenetic analysis was carried out using NDV fusion protein gene 
sequences, which were either obtained during this study, or reference 
sequences obtained from the Genbank. The strain name, host, region and 
year of isolation, genotype assignment and accession numbers, for all 
sequences used in the analysis are shown in Table (3). The analysis involved 
the construction of two phylogenetic trees. 
In the first tree (Figure 5), the first 374 nucleotides of the NDV fusion 
protein coding sequence were used. Sequences used to construct this tree 
were from Sudanese and reference isolates, including reference isolates of 
genotypes II and VI. It could be shown that NDV strains were separated into 
ten genotypes: I-X, which was in accordance to Tsai et al (2004), Liu et al 
(2003), Lien et al (2007), Xu et al (2008), Liu et al (2008 a, b). 
In the second tree (Figure 6), sequences obtained in this study for the seven 
Sudanese strains were used together with reference sequences of genotypes 
II and VI. For each strain and reference strain, a sequence of the length of 
894 nucleotides covering the region from nucleotide 588 to 1481 of the 
fusion protein coding sequence was utilized. Based on the results of this 
analysis, all Sudanese NDV strains used in this study can be divided into 
two clusters, which represent the genotypes II and VI. Two out of seven 
NDV strains, namely Dik-90 and TY-1/90 strains were phylogenetically 
related to genotype VI within the subtype VIb viruses, and, thus, they are 
clustered together with the reference strains 1168/84, JS-2/98(Go) and 
Ch/98-1 previously shown to be belonging to this subtype (Lomniczi et al., 
1998, Liu, et al., 2003, Lien et al., 2007, Liu et al., 2008a, YU et al., 2001). 
Within the subtype VIb, the Sudanese strains showed a closer genetic 
47 
 
relationship to a reference strain from England (1168/84) isolated during a 
1984 outbreak (Collins et al., 1996) than to reference strains from China (JS-
2/98(Go)(Liu et al., 2003) and Ch/98-1(YU, et al., 2001) isolated in 1998. It 
is interesting to mention that the Sudanese isolates (SD-2/75, SD-3/75, SD-
4/75) from the mid-1970 (Ujvári et al., 2003) also fall within group VIb and 
were also closely related to the English strain 1168/84 (Figure 5). 
Figure (6) also shows the other two Sudanese strains Dongola and GD.S.1 in 
addition to the vaccine strains I2, Lasota and Clone 30, clustering into 
another genetic lineage, genotype II viruses, together with the reference 
vaccine strains clone 30, Lasota, V4 and B1 known to be belonging to this 
genotype (Lomniczi et al., 1998, Qin, et al., 2008).  
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Figure (5). Rooted phylogenetic tree of the nucleotide sequences of the fusion protein 
gene of Newcastle disease virus strains. Previously described designations of genetic 
groups and provisional subtypes are shown on the right. Numbers at branching points 
are bootstrap values in percentage.  
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Figure (6). Rooted phylogenetic tree of genotype II and VI strains based on a variable 
region (588-1481) of the fusion protein gene. Previously described designations of 
genetic groups and provisional subtypes of reference strains are shown next to the name 
of the strains. For the strains used in this study (I2, LASOTA, CLONE 30, TY-1/90, DIK-
90, GD.S.1, and DONGOLA) no designation of genotype or subtype is shown  
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Table (3). Referential Newcastle disease virus (NDV) strains used in this 
study for phylogenetic analysis of the fusion protein gene 
 
Strain  Host Year Country Genotype Accession 
number 
Ulster 2C/67 Fowl 1967 Northern 
Ireland 
I D00243 
V4 Queensland/66 Fowl 1966 Australia I M24693 
Beaudette C/45 Fowl 1945 USA II X04719 
La Sota/46 Fowl 1946 USA II M24696 
Texas G.B 48 Fowl 1948 USA II M24698 
B1 Fowl 2000 USA II AF309418 
V4 Fowl 2003 China II AY225110 
Clone 30 Fowl  2005 _ II Y18898 
LaSota Fowl  1999 Netherlands II AF077761 
Miyadera/51 Fowl 1951 Japan III M18456 
Miyadera/51/1 Fowl 1951 Japan III M24701 
Herts/33 Fowl 1933 UK IV M24702 
Italien/45 Fowl 1945 Italy IV M17710 
BSDCK72176 Chicken 2003 Sudan IV AY135753 
Chicken/Sudan/Obied/ 
1987 
Chicken 1987 Sudan IV GQ258674 
CA 1085/71 Fowl 1971 USA. V AF001106 
H-10/72 Fowl 1972 Hungary V AF001107 
SD-2/75 Chicken 1975 Sudan 
(Kuku) 
VI AY151384 
SD-3/75 Chicken 1975 Sudan 
(Kuku) 
VI AY151383 
SD-4/75 Chicken 1975 Sudan 
(Groufli) 
VI AY151385 
Kuwait 256 Fowl 1968 Kuwait VIa AF001109 
Lebanon 70 Fowl 1970 Lebanon VIa AF001110 
GB1168/84 Pigeon 1984 England VIb AF109885 
JS-2/98(Go) Goose 1998 China VIb AF456439 
Ch/98-1 Pigeon 1998 China VIb AF358785 
H-310/82 Fowl 1998 Hungary VIc AF001112 
DK-6/95 Ostrich 1995 Denmark VId AF001130 
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A-24/96 Fowl 1996 Austria VId AF001133 
Warwick/66 Fowl 1966 Great Britain VIe Z12111 
JX-1/94 Fowl 1994 China VIf AF458021 
ZhJ-2/86 Fowl 1986 China VIg AF458016 
Sh-1/97 Fowl 1997 China VIg AF458018 
TW-C69-2-9 Chicken 1969 Taiwan VIh AY372129 
TW-C81-4-3 Chicken 1981 Taiwan VIh AY372133 
DE 143/95 Fowl 1995 Germany VIIa AF109881 
RI-3/88 Fowl 1988 Indonesia VIIa AF001135 
ZA 360/95 Ostrich 1995 South Africa VIIb AF109876 
AE 232/1/96 Partridge 1996 United Arab 
Emirates 
VIIb AF109884 
CH-A7/96 Fowl 1996 China VIIc AY028995 
JS-3/00 Fowl 2000 China VIIc AF458010 
ZJ-1/00(Go) Goose 2000 China VIId AF456438 
XJ-2/97 Fowl 1997 China VIId AF458011 
Chicken/Sudan/02/2005 Chicken 2005 Sudan VIId GQ258669 
Chicken/Sudan/08/2004 Chicken 2004 Sudan VIId GQ258675 
Chicken/Sudan/05/2004 Chicken 2004 Sudan VIId GQ258672 
Chicken/Sudan/04/2003 Chicken 2003 Sudan VIId GQ258671 
Chicken/Sudan/03/2003 Chicken 2003 Sudan VIId GQ258670 
Chicken/Sudan/06/2006 Chicken 2006 Sudan VIId GQ258673 
Taiwan 95 Fowl 1995 Taiwan VIIe U62620 
AF 2240 Fowl 1998 Malaysia VIII AF048763 
QH-4/85 Fowl 1985 China VIII AF378252 
F48E9 Fowl 1948 China IX AF163440 
FJ-1/85 Fowl 1985 China IX AF458009 
TW-C69-10-36 Chicken 1969 Taiwan X AY372163 
TW-C81-4-6 Chicken 1981 Taiwan X AY372137 
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CHAPTER FOUR 
DISCUSSION 
 
Newcastle disease is the most important disease of poultry throughout the 
world because of its high morbidity and mortality (Alexander, 2000b; Cross, 
1991). Because vaccination is the main method of controlling the disease, 
many vaccines have been developed (Gallili and Ben-Nathan, 1998; 
Jorgensen, 1996; Mast et al., 2006; Zhang et al., 2007). However, the 
disease is still enzootic in some areas of the world and remains a constant 
threat to domestic poultry.  
In the Sudan, ND is one of the most widespread poultry diseases and has 
been reported since 1951 (Anon, 1950-1951) but the virus was isolated and 
identified for the first time in the country in 1962 (Karrar and Mustafa, 
1964; Esia, 1979). Since then it continues to be mentioned in all reports of 
the veterinary services. According to Ballouh et al (1983), twelve NDV 
isolates obtained during 1963-1979 in the Sudan were mesogenic (n=4) and 
velogenic (n=8). During the year 1984-1985, four virus isolates were found 
to be velogenic (Haroun et al., 1992). In another study, six isolates were 
obtained from outbreaks in the country between 1988 and 1991 and found to 
possess the characteristics of the viscerotropic velogenic strains of NDV 
[VVNDV] (Khallafalla et al., 1992). Khallafalla et al (1992) concluded that 
the VVNDV is the most prevalent pathotype in the Sudan. 
The genome of NDV comprises a single stranded non-segmented negative 
sense RNA that codes, among others, for two surface glycoprotein, the 
hemagglutinin-neuraminidase (HN) protein and the fusion (F) protein. While 
the HN protein has an undefined role in fusion, the known function of the F 
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protein is to mediate fusion (Lamb, 1993). Moreover, the F protein cleavage 
site plays an important role in NDV virulence, which is associated with 
differences in the amino acid sequence surrounding the post-translational 
cleavage site (Collins et al., 1993; de Leeuw et al., 2005; Panda et al., 2004).  
The use of RT-PCR and sequencing of the F gene of NDV have opened up 
the possibility for accurate virus pathotyping and phylogentic studies, which 
proved important in terms of ND vaccination and eradication.  
Studies on genotypic variations in NDV in Sudan are scarce and only three 
publications, namely Ujvári et al (2003), Aldous et al (2003) and Hassan et 
al (2009), contained genotypic information on some Sudanese NDV isolates, 
but without a link to classical pathotyping or the circulation and origin of 
this devastating virus. 
The goal of this study was to determine the genotype of some NDV isolated 
in Sudan between 1988 and 1999 and to give insights into their origin and 
circulation. 
Four strains of NDV, 2 velogenic (TY-1/90 and DIK-90) and 2 lentogenic 
(Dongola and GD.S.1), in addition to 3 vaccinal strains (Lasota, Clone 30 
and I2) were selected for this study. A number of 894 nucleotides of the 
fusion protein gene of each of the strains was sequenced and analyzed before 
a phylogenetic tree was constructed. 
Our results and analysis showed that TY-1/90 and DIK-90 strains belong to 
genotype VI subtype VIb. These two strains originated from natural severe 
outbreaks of ND in Tayba, 30 Km south of Khartoum, in July 1990 (TY-
1/90) and Dikheinat, 15 Km south of Khartoum, in September 1990 (DIK-
90) (Khalafalla et al., 1992) respectively. According to the classical 
pathotyping, TY-1/90 and DIK-90 strains were described as viscerotropic 
velogenic, due to the fact that they kill chicken embryos quickly and produce 
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haemorrhagic lesions in the intestinal tract in infected chickens (Khalafalla 
et al., 1992). The mean death time (MDT) and intracerebral pathogenicity 
index (ICPI) values used in the pathotyping were similar to those described 
by Hanson et al (1973) for the viscerotropic pathotypes of NDV.  
Genotype VI has been shown to be characterized by frequent branching and 
repeated epizootics caused by molecular variants separated by only short 
evolutionary intervals (Lomniczi et al., 1998). The genotype was divided 
into eight subtypes (a-h) (Liu et al., 2003; Tsai et al., 2004; Lien et al., 
2007). Subtype VIb is comprised solely of viruses associated with panzootic 
infection in pigeons (Columba livia) (Aldous et al., 2003) and isolates 
studied so far usually belonged to mAb group P (Alexander et al., 1997). 
Pigeon isolates were broadly separated into three clusters: The first included 
mainly pre-1996 UK isolates, the second included other European isolates 
before 1998, and the third contained European viruses isolated since 1995 
(Aldous et al., 2003). 
The mid-1970s recorded outbreaks of ND occurring in chicken in Sudan that 
were caused by Genotype VI including SD-2/75, SD-3/75 and SD-4/75 
strains (Ujvári et al., 2003). Interestingly, the above mentioned Sudanese 
isolates cluster together with subtype VIb strains, were distinct from Middle 
Eastern isolates of subtype VIa, and genetically similar to TY-1/90 and 
DIK-90. This indicates a genetic stability of the virus over at least 15 years 
(1975-1990). This sequence stability will help to retrace the progress of the 
virus in the Sudan. 
In addition, SD-2/75, SD-3/75 and SD-4/75, isolates showed a close genetic 
relationship to early European and North American strains, which were 
responsible for the infection of avian paramyxovirus type 1 of pigeons 
(PPMV-1) in the 1980s. There has been a wide believe that PPMV-1 strains 
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emerged as a result of multiple events of chicken-to-pigeon transmission 
(Alexander and Parsons, 1986; Werner et al., 1999; Meulemans et al., 2002). 
Since the local Sudanese isolates of the mid 1970s (SD-2/75, SD-3/75 and 
SD-4/75) and TY-1/90, DIK-90 are genetically closely related to the PPMV-
1 of the 1980s strains, it could be suggested that while they kept circulating 
in Sudan till at least the 1990s, they also possibly gave origin to the 
European and North American pigeon PPMV-1 viruses of the 1980s. This is 
in accordance with Ujvári et al (2003) who suggested that PPMV-1 strains 
could have originated in North-East Africa. The suggestion that TY-1/90 and 
DIK-90 are epidemiologically linked to the 1980s outbreak from Europe is 
strengthened by the fact that they are in close genetic relationship to Great 
Britain GB1168/84 isolate from pigeon in 1984 of subtype (VIb). 
On the other hand, it could be postulated that TY-1/90 and DIK-90 strains 
entered Sudan during the above mentioned ND panzootic in pigeon during 
the 1980s, which was reported in several countries in the Middle East and 
North Africa thereafter (Ujvári et al., 2003). However, it remains to be 
proved whether pigeon PMV-1 (genotype VI subtype VIb) viruses could 
revert to infect chicken.  
Our results showed that the Sudanese strains Dongola and GD.S.1 belong to 
genotype II, and the three vaccinal strains (Lasota, Clone 30 and I2) 
analyzed in this report also list in this genotype. Genotype II consists 
primarily of viruses that were isolated from 1945 to 2000 worldwide, 
varying from virulent to mild isolates (Aldous et al., 2003). Generally, 
genotype II has two subclusters a velogenic and a letogenic (Qin et al., 
2008). The Beaudette C/45 and Texas48 isolates, which have a polybasic-F0 
cleavage site motif typical for velogenic NDV strain fall into one subcluster, 
while the reference vaccine strains (Lasota, B1, Clone 30, La Sota/46 and 
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V4), which have a motif typical for lentogenic NDV strain fall into the other 
subcluster. All the above mentioned isolates analyzed in this study fell into 
the lentogenic cluster of genotype II.  
For Dongola strain, this result is in accordance with the previous findings of 
Khalafalla (1994). The author described Dongola strain, which was isolated 
in 1988 from apparently healthy chickens in Dongola town of Northern 
Sudan, as a lentogenic pathotype of NDV, causing a mild or inapparent 
infection of the respiratory tract. The study of the mAb binding pattern 
placed Dongola strain in group (E) of paramyxoviruses (Khalafalla, 1994). 
The results obtained for GD.S.1, which was isolated from Gedarif in June 
1999, are in contrast with previous description of the strain as velogenic 
(Abdelaziz, 2001). 
It can be concluded that both lentogenic and velogenic NDV exist in Sudan. 
Genotype VI of NDV has been maintained since 1970s and till at least the 
1990. This genotype has probably given origin to PPMV-1 strains of the 
1980s. During the same period of time, other genotypes of NDV existed in 
Sudan. Genotype IV was isolated from domestic fowls on two occasions; in 
1987 (Hassan et al., 2009) and in 1991 (Aldous et al., 2003). More recently, 
genotype VIId was isolated from vaccinated immature and adult layer flocks 
in Khartoum State and eastern Sudan (Gadarif) between 2003 and 2006 
(Hassan et al., 2009). Therefore, further studies utilizing phylogenetic 
analysis are necessary to enable a full view on the evolving status of ND in 
Sudan, to trace the sources of infection, and to assist in taking decisions to 
improve the disease control efforts. 
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APPENDIX ONE 
Preparation of materials 
Agarose 2% 
0.75 gm of agarose (Sigma, UK) was dissolved in 25 ml of TBE buffer 
heated in microwave for 45 seconds, left to cool and poured onto 
electrophoresis chamber. 
 
Running Buffer (TE buffer) 
10 mM Tris-HCl (pH 7.6), 1 mM EDTA. 
 
Ethidium bromide 
Stock solution (PROMEGA, Madison) kept protected from light. 
 
6X Loading Dye Solution 
10 mM Tris-HCl (pH 7.6), 0.03% bromophenol blue, 0.03% xylene cyanol 
FF, 60% glycerol and 60mM EDTA. 
 
GeneRuler™ 1kb DNA Ladder 
The Ladder is composed of fifteen chromatography-
purified individual DNA fragments (in base pairs): 
20000, 10000, 7000, 5000, 4000, 3000, 2000, 1500, 
1000, 700, 500, 400, 300, 200, and 75. It contains 
three reference bands (5000, 1500 and 500 bp) for easy 
orientation. The Ladder is dissolved in TBE buffer. 
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Phosphate buffered saline solution (PBS) 2 liters 
Solution (A) 
NaCl 16 gm 
KCl 0.4 gm 
Na2HPO4 0.4 gm 
DDW To 1500 ml 
 
Solution (B) 
MgCl26H2O(hydrous) 0.426 gm 
DDW To 200 ml 
 
Solution (C) 
CaCl2 (hydrous) 0.426 gm 
DDW To 200 ml 
 
Solution (A) (B) and (C) were autoclaved and left to cool. To prepare 
working solution of PBS, solution (A) and (B) were mixed. Solution (C) was 
then added and the final volume was brought to 2 liters with sterile DDW. 
Working solution of Antibiotics for chick embryo inoculation 
Amphotricin B stock solution  0.5 ml 
Streptomycin stock solution 0.5 ml 
PBS 0.8 ml 
Total 1.8 ml 
 
0.1µl was used per egg 
 
83 
 
APPENDEX TWO 
Annotated sequences of Newcastle disease virus produced 
during this study 
 
>I_2. 
ATTAGACTGCATCAAAATTGCACAGCAAGTTGGTGTAGAGCTCAACCTGTACCTAACCGAATTGACTACAGT
ATTCGGACCACAAATCACTTCACCTGCTTTAAACAAGCTGACTATTCAGGCACTTTACAATCTAGCTGGTGG
AAATATGGATTACTTATTGACTAAGTTAGGTGTAGGGAACAATCAACTCAGCTCATTAATCGGTAGCGGCTT
AATCACCGGTAACCCTATTCTATACGACTCACAGACTCAACTCTTGGGTATACAGGTAACTCTACCTTCAGT
CGGGAACCTAAATAATATGCGTGCCACCTACTTGGAAACCTTATCCGTAAGCACAACCAGGGGATTTGCCTC
GGCACTTGTCCCAAAAGTGGTGACACAGGTCGGTTCTGTGATAGAAGAACTTGACACCTCATACTGTATAGA
AACTGACTTAGATTTATATTGTACAAGAATAGTAACGTTCCCTATGTCCCCTGGTATTTATTCCTGCTTGAG
CGGCAATACGTCGGCCTGTATGTACTCAAAGACCGAAGGCGCACTTACTACACCATACATGACTATCAAAGG
TTCAGTCATCGCCAACTGCAAGATGACAACATGTAGATGTGTAAACCCCCCGGGTATCATATCGCAAAACTA
TGGAGAAGCCGTGTCTCTAATAGATAAACAATCATGCAATGTTTTATCCTTAGGCGGGATAACTTTAAGGCT
CAGTGGGGAATTCGATGTAACTTATCAGAAGAATATCTCAATACAAGATTCTCAAGTAATAATAACAGGCAA
TCTTGATATCTCAACTGAGCTTGGGAATGTCAACAACTCGATCAGTAATgCTTTGAATAAGTTAGAGGAAAG
CAACAGAAAACTAGACAAAGTCAATGTCAA 
>TY-1/90. 
ATTGGACTGTATAAAAATTACACAACAAGTCGGTGTAGAACTCAACCTATACCTAACTGAATTGACTACGGT
GTTTGGGCCGCAAATCACTTCCCCTGCCCTAACTCAGCTGACTATCCAGGCACTTTATAATTTAGCTGGTGG
CAATATGGATTACTTGTTGACTAAGTTAGGTGTAGGGAACAATCAACTCAGCTCATTAATTGGTAGTGGCTT
GATCACAGGCCACCCTATACTGTATGACTCACAGACTCAGCTCCTGGGCATACAGGTAAATTTACCCTCAGT
CGGGAACCTTAATAATATGCGTGCCACCTACTTGGAGACTTTATCCGTAAGCACAACCAAGGGGTTTGCCTC
AGCACTTGTCCCGAAGGTAGTGACACAAGTCGGTTCCGTGATAGAAGAACTTGACACCTCACACTGTATAGA
GTCTGATCTGGATTTATATTGTACAAGAATAGTGACATTCCCCATGTCTCCAGGCATTTATTCCTGTCTGAG
TGGCAACACATCAGCTTGCATGTACTCAAAGACTGAAGGTGCACTCACTACGCCATATATGGCCCTCAAAGG
CTCAGTTGTTGCCAATTGCAAAATAACAACATGTAGGTGCGCAGACCCTCCAGGTATCATATCGCAAAACTA
TGGAGAAGCTGTATCTCTGATAGATAGACATTCATGCAATGTCTTGTCACTAGATGGGATAACTCTGAGGCT
TAGTGGGGAGTTTGATGCAACTTATCAAAAGAATATCTCAATACTAGATTCTCAAGTCATCGTGACAGGCAA
TCTTGATATATCAACCGAGCTTGGAAATGTCAACAATTCAATAAGCAATGCCCTGGGCAAGTTAGCGGAAAG
TAACAGCAAACTAGACAAAGTCAATATCAA 
>Clone_30. 
ATTAGACTGCATCAAAATTGCACAGCAAGTTGGTGTAGAGCTCAACCTGTACCTAACCGAATTGACTACAGT
ATTCGGACCACAAATCACTTCACCTGCTTTAAACAAGCTGACTATTCAGGCACTTTACAATCTAGCTGGTGG
AAATATGGATTACTTATTGACTAAGTTAGGTGTAGGGAACAATCAACTCAGCTCATTAATCGGTAGCGGCTT
AATCACCGGTAACCCTATTCTATACGACTCACAGACTCAACTCTTGGGTATACAGGTAACTCTACCTTCAGT
CGGGAACCTAAATAATATGCGTGCCACCTACTTGGAAACCTTATCCGTAAGCACAACCAGGGGATTTGCCTC
GGCACTTGTCCCAAAAGTGGTGACACAGGTCGGTTCTGTGATAGAAGAACTTGACACCTCATACTGTATAGA
AACTGACTTAGATTTATATTGTACAAGAATAGTAACGTTCCCTATGTCCCCTGGTATTTATTCCTGCTTGAG
CGGCAATACGTCGGCCTGTATGTACTCAAAGACCGAAGGCGCACTTACTACACCATACATGACTATCAAAGG
TTCAGTCATCGCCAACTGCAAGATGACAACATGTAGATGTGTAAACCCCCCGGGTATCATATCGCAAAACTA
TGGAGAAGCCGTGTCTCTAATAGATAAACAATCATGCAATGTTTTATCCTTAGGCGGGATAACTTTAAGGCT
CAGTGGGGAATTCGATGTAACTTATCAGAAGAATATCTCAATACAAGATTCTCAAGTAATAATAACAGGCAA
TCTTGATATCTCAACTGAGCTTGGGAATGTCAACAACTCGATCAGTAATGCTTTGAATAAGTTAGAGGAAAG
CAACAGAAAACTAGACAAAGTCAATGTCAA 
>Dik_90. 
ATTGGACTGTATAAAAATTACACAACAAGTCGGTGTAGAACTCAACCTATACCTAACTGAATTGACTACGGT
GTTTGGGCCGCAAATCACTTCCCCTGCCCTAACTCAGCTGACTATCCAGGCACTTTATAATTTAGCTGGTGG
CAATATGGATTACTTGTTGACTAAGTTAGGTGTAGGGAACAATCAACTCAGCTCATTAATTGGTAGTGGCTT
GATCACAGGCCAACCTATACTGTATGACTCACAGACTCAGCTCCTGGGCATACAGGTAAATTTACCCTCAGT
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CGGGAACCTTAATAATATGCGTGCTACCTACTTGGAGACTTTATCCGTAAGCACAACCAAGGGGTTTGCCTC
AGCACTTGTCCCGAAGGTAGTGACACAAGTCGGCTCCGTGATAGAAGAACTTGACACCTCATACTGTATAGA
GTCTGATCTGGATTTATATTGTACAAGAATAGTGACATTCCCCATGTCTCCAGGCATTTATTCCTGTCTGAG
TGGCAACACATCAGCTTGCATGTACTCAAAGACTGAAGGTGCACTCACCACGCCATATATGGCCCTCAAAGG
CTCAGTTATTGCCAATTGCAAAATAACAACATGTAGGTGCGCAGACCCCCCAGGTATCATATCGCAAAACTA
TGGAGAAGCTGTATCTCTGATAGATAGACATTCATGCAATGTCTTGTCACTAGACGGGATAACTCTGAGGCT
TAGTGGGGAGTTTGATGCAACTTATCAAAAGAATATCTCAATACTAGATTCTCAAGTCATCGTGACAGGCAA
TCTTGATATATCAACCGAGCTTGGAAATGTCAACAATTCAATAAGCAATGCCCTGGGCAAGTTAGCGGAAAG
TAACAGCAAACTAGACAAAGTCAATgtCAA 
>GD_S_1. 
ATTAGACTGCATCAAAATTGCACAGCAAGTTGGTGTAGAGCTCAACCTGTACCTAACCGAATTGACTACAGT
ATTCGGACCACAAATCACTTCACCTGCTTTAAACAAGCTGACTATTCAGGCACTTTACAATCTAGCTGGTGG
AAATATGGATTACTTATTGACTAAGTTAGGTGTAGGGAACAATCAACTCAGCTCATTAATCGGTAGCGGCTT
AATCACCGGTAACCCTATTCTATACGACTCACAGACTCAACTCTTGGGTATACAGGTAACTCTACCTTCAGT
CGGGAACCTAAATAATATGCGTGCCACCTACTTGGAAACCTTATCCGTAAGCACAACCAGGGGATTTGCCTC
GGCACTTGTCCCAAAAGTGGTGACACAGGTCGGTTCTGTGATAGAAGAACTTGACACCTCATACTGTATAGA
AACTGACTTAGATTTATATTGTACAAGAATAGTAACGTTCCCTATGTCCCCTGGTATTTATTCCTGCTTGAG
CGGCAATACGTCGGCCTGTATGTACTCAAAGACCGAAGGCGCACTTACTACACCATACATGACTATCAAAGG
TTCAGTCATCGCCAACTGCAAGATGACAACATGTAGATGTGTAAACCCCCCGGGTATCATATCGCAAAACTA
TGGAGAAGCCGTGTCTCTAATAGATAAACAATCATGCAATGTTTTATCCTTAGGCGGGATAACTTTAAGGCT
CAGTGGGGAATTCGATGTAACTTATCAGAAGAATATCTCAATACAAGATTCTCAAGTAATAATAACAGGCAA
TCTTGATATCTCAACTGAGCTTGGGAATGTCAACAACTCGATCAGTAATGCTTTGAATAAGTTAGAGGAAAG
CAACAGAAAACTAGACAAAGTCAATGTCAA 
>LASOTA. 
ATTAGACTGCATCAAAATTGCACAGCAAGTTGGTGTAGAGCTCAACCTGTACCTAACCGAATTGACTACAGT
ATTCGGACCACAAATCACTTCACCTGCTTTAAACAAGCTGACTATTCAGGCACTTTACAATCTAGCTGGTGG
AAATATGGATTACTTATTGACTAAGTTAGGTGTAGGGAACAATCAACTCAGCTCATTAATCGGTAGCGGCTT
AATCACCGGTAACCCTATTCTATACGACTCACAGACTCAACTCTTGGGTATACAGGTAACTCTACCTTCAGT
CGGGAACCTAAATAATATGCGTGCCACCTACTTGGAAACCTTATCCGTAAGCACAACCAGGGGATTTGCCTC
GGCACTTGTCCCAAAAGTGGTGACACAGGTCGGTTCTGTGATAGAAGAACTTGACACCTCATACTGTATAGA
AACTGACTTAGATTTATATTGTACAAGAATAGTAACGTTCCCTATGTCCCCTGGTATTTATTCCTGCTTGAG
CGGCAATACGTCGGCCTGTATGTACTCAAAGACCGAAGGCGCACTTACTACACCATACATGACTATCAAAGG
TTCAGTCATCGCCAACTGCAAGATGACAACATGTAGATGTGTAAACCCCCCGGGTATCATATCGCAAAACTA
TGGAGAAGCCGTGTCTCTAATAGATAAACAATCATGCAATGTTTTATCCTTAGGCGGGATAACTTTAAGGCT
CAGTGGGGAATTCGATGTAACTTATCAGAAGAATATCTCAATACAAGATTCTCAAGTAATAATAACAGGCAA
TCTTGATATCTCAACTGAGCTTGGGAATGTCAACAACTCGATCAGTAATGCTTTGAATAAGTTAGAGGAAAG
CAACAGAAAACTAGACAAAGTCAATGTCAA 
>DONGOLA. 
ATTAGACTGCATCAAAATTGCACAGCAAGTTGGTGTAGAGCTCAACCTGTACCTAACCGAATTGACTACAGT
ATTCGGACCACAAATCACTTCACCTGCTTTAAACAAGCTGACTATTCAGGCACTTTACAATCTAGCTGGTGG
AAATATGGATTACTTATTGACTAAGTTAGGTGTAGGGAACAATCAACTCAGCTCATTAATCGGTAGCGGCTT
AATCACCGGTAACCCTATTCTATACGACTCACAGACTCAACTCTTGGGTATACAGGTAACTCTACCTTCAGT
CGGGAACCTAAATAATATGCGTGCCACCTACTTGGAAACCTTATCCGTAAGCACAACCAGGGGATTTGCCTC
GGCACTTGTCCCAAAAGTGGTGACACAGGTCGGTTCTGTGATAGAAGAACTTGACACCTCATACTGTATAGA
AACTGACTTAGATTTATATTGTACAAGAATAGTAACGTTCCCTATGTCCCCTGGTATTTATTCCTGCTTGAG
CGGCAATACGTCGGCCTGTATGTACTCAAAGACCGAAGGCGCACTTACTACACCATACATGACTATCAAAGG
TTCAGTCATCGCCAACTGCAAGATGACAACATGTAGATGTGTAAACCCCCCGGGTATCATATCGCAAAACTA
TGGAGAAGCCGTGTCTCTAATAGATAAACAATCATGCAATGTTTTATCCTTAGGCGGGATAACTTTAAGGCT
CAGTGGGGAATTCGATGTAACTTATCAGAAGAATATCTCAATACAAGATTCTCAAGTAATAATAACAGGCAA
TCTTGATATCTCAACTGAGCTTGGGAATGTCAACAACTCGATCAGTAATGCTTTGAATAAGTTAGAGGAAAG
CAACAGAAAACTAGACAAAGTCAATGTCAA 
